Improving the Performance and Precision of Bioinformatics Algorithms by Wu, Xue
ABSTRACT
Title of dissertation: Improving the Performance and Precision of
Bioinformatics Algorithms
Xue Wu, Doctor of Philosophy, 2008
Dissertation directed by: Professor Chau-Wen Tseng
Department of Computer Science
Recent advances in biotechnology have enabled scientists to generate and col-
lect huge amounts of biological experimental data. Software tools for analyzing both
genomic (DNA) and proteomic (protein) data with high speed and accuracy have
thus become very important in modern biological research. This thesis presents
several techniques for improving the performance and precision of bioinformatics
algorithms used by biologists.
Improvements in both the speed and cost of automated DNA sequencers have
allowed scientists to sequence the DNA of an increasing number of organisms. One
way biologists can take advantage of this genomic DNA data is to use it in con-
junction with expressed sequence tag (EST) and cDNA sequences to find genes and
their splice sites. This thesis describes ESTmapper, a tool designed to use an eager
write-only top-down (WOTD) suffix tree to efficiently align DNA sequences against
known genomes. Experimental results show that ESTmapper can be much faster
than previous techniques for aligning and clustering DNA sequences, and produces
alignments of comparable or better quality.
Peptide identification by tandem mass spectrometry (MS/MS) is becoming the
dominant high-throughput proteomics workflow for protein characterization in com-
plex samples. Biologists currently rely on protein database search engines to identify
peptides producing experimentally observed mass spectra. This thesis describes two
approaches for improving peptide identification precision using statistical machine
learning.
HMMatch (HMM MS/MS Match) is a hidden Markov model approach to
spectral matching, in which many examples of a peptide fragmentation spectrum
are summarized in a generative probabilistic model that captures the consensus and
variation of each peak’s intensity. Experimental results show that HMMatch can
identify many peptides missed by traditional spectral matching and search engines.
PepArML (Peptide Identification Arbiter by Machine Learning) is a machine
learning based framework for improving the precision of peptide identification. It
uses classification algorithms to effectively utilize spectra features and scores from
multiple search engines in a single model-free framework that can be trained in an
unsupervised manner. Experimental results show that PepArML can improve the
sensitivity of peptide identification for several synthetic protein mixtures compared
with individual search engines.
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Since the discovery of the DNA double helix in 1953 by James Watson and
Francis Crick, scientists have been trying to understand biology in molecular terms.
Subsequently, the discovery of automated techniques to sequence DNA in the late
1970s and the fast development of protein chemistry in 1980s have mad study-
ing organisms at the molecular level increasingly effective. Today, the continuous
advances in molecular biology and corresponding experimental techniques have pro-
duced a huge amount of biological data generated by different types of automated
techniques. As a result, computational tools have become essential in both genomics
and proteomics for analyzing these biological data with high speed and accuracy.
In this thesis, three carefully designed algorithms are presented to demonstrate
that computer scientists can contribute to the area of computational biology by
finding ways to improve the performance and precision of bioinformatics algorithms
commonly used by biologists, in ways that yield practical benefit for their biological
research. These three algorithms were especially designed to demonstrate the ability
of high performance computing and statistical machine learning in boosting both
the performance and precision of bioinformatics algorithms.
The remainder of this chapter will begin by providing a brief introduction to
genomics, proteomics and bioinformatics. In addition to providing basic background
1
knowledge for the rest of the thesis, we also present reasons why high performance
computing and statistical machine learning techniques are helpful for solving molec-
ular biology problems. Our motivation for designing the algorithms is provided at
the end of the chapter.
1.1 Genomics
Genomics is the study of the entire genome of an organism. It includes both
determining the entire set of DNA sequences of an organism and understanding
an organism’s genetic mapping. Since DNA sequence stores genetic information of
all known living organisms, it is very important to understand its structure and
function.
1.1.1 DNA Contains Basic Genetic Information
DNA is a macromolecule composed of a sequence of deoxyribonucleotides each
containing a base, a sugar, and a phosphate group. Since DNA contains four different
kinds of nucleotide bases (adenine (A), guanine (G), thymine (T) and cytosine (C)),
DNA sequences may be written as strings constructed from an alphabet of four
letters, namely A, C, G, and T.
DNA’s three-dimensional structure is a double helix, which was discovered by
James Watson and Francis Crick in 1953. In this structure, sugar and phosphate
groups form the backbone and complementary bases (A-T, C-G) are connected by
hydrogen bond.
2
DNA contains the basic genetic information that each organism needs to live
and reproduce. The complete set of DNA that contains entire hereditary information
of an organism is called the genome of the organism. The part of the genome that
contains the hereditary information (producing proteins) are called genes. Human
genome is believed to contain up to 20,000–25,000 genes (this estimate may change
as human genome sequencing projects progress).
1.1.2 Genome Sequencing and Assembly
Since the genome contains such important information about organisms, ob-
taining the genome sequences of living organisms is widely considered to be the first
step towards a deeper understanding of genetics and biology in general. Early DNA
sequencing methods were slow and labor intensive. For instance, Maxim-Gilbert
chemical sequencing involved gel electrophoresis and radioactive labeling [MG77].
Development of the Sanger (dideoxy termination) method greatly increased
the ease of DNA sequencing [SNC77]. The method can be used to determine short
(500–1000) nucleotides sequences off the end of a DNA fragment (called reads).
Once the process was automated using capillary electrophoresis by companies such
as Applied Biosystems, fast and inexpensive large-scale DNA sequencing become
feasible and eventually led to sequencing of the genomes of many species.
Because DNA sequencers only produce many short DNA sequences, assembly
techniques were developed to reconstruct the original DNA sequence by looking
for overlaps between the short reads. The success of assembly tools enabled entire
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genomes to be sequenced [ISF+04] using shotgun sequencing, where many random
fragments from a long DNA sequence are sequenced and assembled to construct the
original sequence [SCH+82].
1.1.3 Gene Structure and Genomic Annotation
Sequencing genomes is only one goal of genomic research. Once a genome has
been sequenced, genome annotation seeks to label each part of the genome with
its function. An important part of genome annotation is discovering what genes
are present and where they are located in the genome. The structure of a gene is
described in Figure 1.1.
Figure 1.1: Gene Structure
As shown in the figure, genes are composed of sections of DNA known as exons
and introns. Exons are regions that remain in mature mRNA and are later translated
into proteins. Introns are regions that are spliced out of mRNA before translation
to protein. The boundaries between introns and exons are called splice sites. Ge-
nomic annotation includes identification of the initiator of translation, splice sites,
promoter and regulatory regions, and several other biologically important elements.
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1.1.4 Gene Finding
Gene finding is the process of discovering genes in the genome. One problem
with gene finding is caused by splicing. Since genes usually contain multiple introns,
they may be produced from multiple regions of genomic DNA, depending on what
introns have been spliced out. The issue is difficult because splice sites are not
unique, and can occur in many different places in the genome.
Exacerbating the problem is alternative splicing, a process where the same
genomic DNA can be spliced in different ways to produce multiple protein isoforms.
In fact, alternative splicing is quite common, and makes determining the location
of genes and correct splice sites even more difficult.
Experimental methods exist for accurate genome annotation (such as produc-
ing full-length cDNAs), but these methods are expensive, and too slow to keep up
with the accelerating speed with which genomic sequence is being produced. For
this reason computational methods play an essential part in gene finding.
Researchers have devised many algorithms for finding genes and their splice
sites, some using statistic modeling techniques such as Hidden Markov Models. But
since the types and location of splice sites are not completely known, the algorithms
cannot locate all genes accurately using only statistic modeling.
Another computational approach to finding genes relies on a type of experi-
mentally acquired data—short expressed DNA sequences called Expressed Sequence
Tags (ESTs). ESTs are short (400-800 bases) single-pass sequences generated from
expressed DNA and relatively easy to collect and sequence in the laboratory. How-
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ever, despite their fragmentary and error-prone nature, ESTs are of interest because
they can be collected from mature mRNA, and can thus be used as evidence for
finding genes, their splice sites, and isoforms created from alternative splicing.
Because of the large size of genomes and enormous number of ESTs, developing
algorithms to efficiently use EST information to find genes poses a computational
challenge. Our first proposed algorithm targets mapping cDNA to genomes and
demonstrates how to solve this problem with high performance computing tech-
niques.
1.2 Proteomics
1.2.1 Proteins are Produced From DNA
Most of the properties of living organisms arise from the class of molecules
known as proteins. Proteins are composed of hundreds to thousands of amino acid
subunits connected in long chains. There are 20 different amino acids, so each can
be represented by a single character in [A, . . . , Z]. Because proteins are a product
of DNA transcription and RNA translation as described by Figure 1.2, the order
of amino acids is determined by genes encoded in the genome. Each amino acid
chain folds in a different way to form a complicated 3 dimensional structure for each
protein.
Proteomics is the study of all proteins of an organism. It strives to provide
detailed information about protein structure, function and control of disease of bio-
logical systems. In the early stages of proteomics, protein chemistry was the major
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Figure 1.2: Protein Generation
research approach to studying protein and the link between gene and protein. In the
1980s and early 1990s, analytical protein chemistry mainly targeted improving the
sensitivity of techniques for identifying proteins separated by gels. These protein se-
quencing results led to important information about proteins and their relationship
with genes. At the same time, mass spectrometry became one of the major experi-
mental techniques for analytical chemists to analyze small molecules. Advances in
analytical protein chemistry, plus mass spectrometry and protein databases, have
made large scale high throughput protein studies possible.
1.2.2 Major Disciplines in Proteomics
Currently there are three major disciplines in proteomics: mass spectrometry
based proteomics, chip based proteomics, and genetic methods for studying the pro-
teome. Among them, mass spectrometry based proteomics is a rapidly developing
research area. Protein mass spectrometry is used for analyzing functional protein
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complexes by identifying not only the members of the complexes, but also the in-
teractions among the members. It is expected to become the main quantitative
technology for systematical protein study.
However, because of the low quality of spectra data and high data generation
speed, the analysis and interpretation of enormous amounts of protein mass spec-
tra data is a major computational challenge. Even though computer scientists and
statisticians have developed many algorithms and techniques for identifying pro-
teins using experimental mass spectra, more precise and efficient algorithms are still
needed.
1.3 Bioinformatics
1.3.1 Computational Processing of Biological Information
Defined as techniques for computational processing of biological information,
bioinformatics requires knowledge from two areas: computer science and biology.
Many fundamental biology problems from the early days of molecular biology have
already demonstrated their need for computational solutions. Topics such as DNA
structure, encoding of genetic information in protein, protein structure, biochemical
pathways, etc., have motivated and defined the development agenda of bioinformat-
ics and computational biology.
Bioinformatics as a research area started with combining computational and
experimental information to better understand biological molecules. Construction
of phylogenetic trees, understanding of DNA sequence properties and protein align-
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ment properties were some early approaches for solving biology problems with com-
putational algorithms. Later, with rapid development of automated experimental
techniques, efficient computer algorithms were developed to cope with the fast grow-
ing amounts of biology data. Bioinformatics and computational biology became an
independent discipline. Researchers in the area of bioinformatics are now striving
to solve biology problems that pose great computational challenges.
1.3.2 Major Bioinformatics Research Topics
Some current bioinformatics research topics include:
• Pairwise and multiple sequence alignments
• Genome assembly
• Gene identification and annotation
• Gene expression analysis
• Protein sequencing
• Protein structure prediction
• Protein interaction
• Phylogenetic analysis
In general, bioinformatics algorithms strive to provide either the most accu-
rate mathematical models for solving the biology problem, or techniques that can
efficiently process large amount of experimental data in a reasonable period of time.
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Bioinformaticians help biologists avoid or reduce expensive and lengthy wetlab ex-
perimental procedures.
In the remainder of the thesis, I will describe three algorithms to demonstrate
the strength of using high performance computing and statistical modeling tech-
niques in bioinformatics applications.
1.4 High Performance Computing
Two techniques widely used in the bioinformatics field are high performance
computing and statistical machine learning. Both techniques play key roles in bio-
logical data analysis.
The necessity of high performance computing techniques arises from the ad-
vance of automated biological experimental techniques producing large data sets.
In recent years, the amount of biological data coming from both genomics and
proteomics have grown at a rapidly increasing rate. As a result bioinformatics
researchers have started to take advantage of high performance computing architec-
tures, including both distributed and shared memory platforms.
Many early high performance computing bioinformatics applications were in
the area of pairwise sequence alignment. AGBLAST, NCBI BLAST [NCB], WU
BLAST [WUB], mpiBLAST [DCF03], and UM-BLAST are different high perfor-
mance versions of BLAST, a very popular sequence alignment tool. These versions
of BLAST use parallel and distributed computer architectures to speed up the se-
quence alignment process. Later tools such as BLAST++ [WOOT03], megaBLAST,
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TGICL, and PaCE exploit data properties and design new algorithms based on spe-
cific data structures to improve sequence alignment performance. Both approaches
are necessary to improve the throughput and processing speed of bioinformatics
tools such as BLAST.
More recently with increasing amounts and types of experimental data, high
performance computing tools have been used in the realms of microarray gene ex-
pression data analysis, genetic networks, protein-protein interactions, phylogeny
reconstruction, protein structure predictions, etc.
1.5 Statistical Machine Learning
Statistical machine learning is another key technique used in bioinformatics. It
provides methods which make it possible to find patterns and automatically generate
predictive models from large data sets, thus helping people understand and analyze
the underlying biological information and mechanisms hidden in the data.
Machine learning plays a vital role in genomics research. Many machine learn-
ing algorithms have been developed to perform splice site prediction, alternative
splicing form recognition, gene annotation and gene function prediction. In the
area of proteomics, machine learning is used to aid protein structure and function
prediction.
More recently, researchers have started to apply machine learning methods to
peptide identification based on tandem mass spectrometry data. Machine learning
has also been used to process microarray data to identify expression pattern and
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study gene networks. In the area of system biology, machine learning has been used
to model biological network to study genetic networks, signal transduction networks
and metabolic pathways. In the area evolutionary biology, machine learning meth-
ods help reconstruct phylogenetic trees to study the evolution of many organisms.
In addition, machine learning has also been used in primer design for PCR and to
help analyze biological images.
Where high performance computing has increased the speed of bioinformatics
algorithms, statistical machine learning has improved the accuracy of bioinformatics
algorithms. Both classes of techniques are are very important tools for bioinformat-
ics research.
1.6 Outline of Thesis
To demonstrate the application of both high performance computing tech-
niques and machine learning techniques in bioinformatics research, two classes of
algorithms are presented to solve two popular problems in genomics and proteomics
fields.
The first class of algorithms are designed for aligning cDNA sequences to
genomes. In genomics, the results of aligning cDNA sequences to genomes can be
used to answer a number of important questions such as gene finding, EST cluster-
ing, finding alternative splicing isoforms, and identifying gene function. However,
because of large genome sizes (thousands to millions of bases) and the huge num-
ber of available cDNA sequences (millions), aligning DNA to genomes can pose
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a challenge for both accuracy and computation speed. In response we developed
ESTmapper, an efficient cDNA to genome alignment algorithm that is carefully
designed to align DNA to genomes with high accuracy and speed.
The second class of algorithms are designed to identify peptides by analyzing
tandem mass spectra from protein samples. Tandem mass spectrometry is a key
technique used for high-throughput protein identification. But due to limitations
of current database search based protein identification algorithms, it is not easy to
improve the accuracy of the results.
We present the design of two algorithms (HMMatch and PepArML) for im-
proving peptide identification accuracy. HMMatch recognizes previously observed
peptide fragmentation patterns to complement database search based methods.
PepArML enhances database search by distinguishing between true and false posi-
tive protein identifications by combining multiple search engine results and exploring
a large feature space.
The final part the thesis summaries the proposed algorithms and concludes
with possible directions for future research.
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Chapter 2
High-throughput EST/cDNA to Genome Mapping
2.1 Background
Recent advances in molecular biology techniques such as automated DNA
sequencing have allowed scientists to quickly gather huge amounts of DNA sequence
data. Two types of DNA sequence data are particularly interesting: genomic DNA
and expressed sequence tags (ESTs). Genomes are long (thousands to millions of
bases) DNA sequences representing the complete DNA of an organism, carefully
constructed with high accuracy from many experiments. In comparison, ESTs are
short (400-800 bases) single-pass DNA sequences that can be collected from mature
mRNA that have already been spliced (introns excised). ESTs are relatively easy
to collect and sequence in the laboratory but are more error-prone since each EST
represents a single read.
With the increasing number of species whose genomes have been sequenced and
the growing collection of EST sequence libraries (the August 2008 version of dbEST
contained 54 million EST sequences from 1605 species), efficiently and accurately
mapping large numbers of ESTs and other DNA sequences to genomes has become a
challenging problem, but one of increasing importance to biologists. Such mappings
may be used to answer a number of important questions, such as:
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Gene finding. Determining which portions of the genome are actual genes is quite
difficult. Many computational gene finding techniques exist for classifying and pre-
dicting genes based on the genomic DNA sequence alone. However, the accuracy of
these techniques can generally be improved by including ESTs from mature mRNAs.
To use this information, ESTs need to be mapped to the appropriate locations in
the genome for inclusion gene finding [SKG04].
EST clustering. Algorithms also exist for finding genes based on ESTs alone, by
forming clusters of overlapping ESTs and assemble the sequences in each clus-
ter [BDH99, MCJ03, PGB02, LHP+00, PHL+03, KAKB03]. EST clusters may
be formed by comparing ESTs against each other to find similarity and overlaps.
Alternatively, clusters may also be formed from ESTs mapped to overlapping and
nearby locations in the genome [CRL+04, LB04].
Alternative splicing. A major source of complexity for gene finding is the fact
that genes can consist of non-contiguous sections of genomic DNA formed through
splicing [DL99, SCK04]. Even worse, variations in splicing can cause a gene to
produce multiple transcripts. Mapping ESTs to the genome can help point out
splice sites and predict alternative splicing [GMXL04, CHV02].
Gene regulation. Whether genomic DNA is actually expressed depends on a num-
ber of factors, but it is known that gene regulation can be affected by DNA sequences
near to but not actually part of the gene. Mapping ESTs and genes to the genome
thus allows biologists to examine the DNA surrounding each gene to look for factors
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affecting gene regulation.
Gene function. Using a number of unique markers in the genome, biologists have
calculated linkage maps predicting the location in the genome of genes responsible
for a number of genetic traits. Mapping genes to a location in the genome thus
improves the ability of biologists to predict gene function to aid in disease diagnosis
and drug design [PSL+04].
2.2 Related Work
Since the ability to align DNA sequences to the genome is so useful, researchers
have investigated many techniques for performing such alignments. One way is to
use traditional pairwise sequence alignment method.
2.2.1 Pairwise Sequence Alignment
Pairwise sequence alignment compares two sequences to find and align the
most similar substrings based on some metric. It is probably the most commonly
performed computation in bioinformatics, and many algorithms have been devel-
oped. Basic Local Alignment Search Tool (BLAST) [AGM+90] is the most popular
and widely used tool for sequence alignment and similarity search. The search strat-
egy is based on using scoring matrices to compare short subsequences (words) in
the query sequence against the entire target DNA or protein sequence database to
find statistically significant matches, then attempting to extend these matches to
find the most similar sequences or subsequences.
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BLAST speeds up local sequence alignment in 3 algorithmic steps. First, it
compiles a list of words of length w. For proteins, the list only consists those words
that score at least T when compared to some word in the query sequence. Next,
BLAST scans through every database sequence to find all the occurrences of the
words in the list. In the third step, the matching words are extended into ungapped
local alignments between the query sequence and the sequence from the database.
Extensions are continued until the score of the alignment drops below a threshold.
The top-scoring alignments are combined into local alignments.
Researchers also designed high performance BLAST algorithms to improve its
throughput when processing large sequence databases. Threaded BLAST [NCB,
WUB], mpiBLAST [DCF03] and BLAST++ [WOOT03] represent three typical
kinds of methods that are used to speed up the BLAST searching further. However,
due to the large size of many genomes (around 3 billion bases for Human and Mouse)
and the large number of DNA sequences collected by biologists, aligning DNA to
genomes pose a computational challenge. Even using high performance BLASTs can
be too expensive when a single high-throughput automated DNA sequencer (e.g.,
ABI Prism 3730xl) can output two million bases of sequence per day.
Producing accurate DNA to genome alignments is also problematic, since
genomes contain many very similar if not duplicate DNA sequences that can re-
sult in multiple plausible alignments to different portions of the genome. Careful
analysis is needed to distinguish between the possible alignments and calculate the
most plausible mapping.
A second (somewhat subtle) issue can also reduce the effectiveness of pairwise
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alignment tools when used to align DNA to genomes. Tools such as BLAST are typ-
ically designed and tuned to find homology between nearby sequences, for instance
the same gene in Human and Mouse. As a result scores and statistical significance of
matches (for instance, BLAST’s substitution/scoring matrix) is usually calculated
based on the similarity of two sequences after an evolutionary period.
In comparison, for DNA to genome alignments we can usually assume the
DNA actually came from the genome, so the sequences should be highly similar. Any
differences arise from splicing and sequencing errors, not as a process of mutation and
evolution. As a result, we expect to find much longer identical common substrings
when comparing query sequences to genomes when compared to typical BLAST
searches. Techniques that take advantage of these observations may be able to
improve the accuracy of their alignments.
2.2.2 cDNA to Genome Alignment
As we have thus seen, standard pairwise sequence alignment techniques face
obstacles when applied to cDNA to genome alignment. As a result researchers
have designed several other alignment techniques ([FHZ+98, Ken02, OM02, WW05,
WCO01]).
megaBLAST. MegaBLAST is a program from the NCBI BLAST software suite
that uses a greedy algorithm to align nucleotide sequences [ZSWM00]. The program
provides good performance for highly similar sequences with minor differences, and
is thus frequently used for genome alignments.
18
BLAT. BLAT is an alternative pairwise sequence alignment algorithm [Ken02].
BLAT maintains a precomputed hash table index of the locations of all non-overlapping
substrings (words) of length k. Performance is dramatically improved because
queries do not need to scan the entire sequence database. Only the sections of
the sequence database with hits in the index need to be examined to compute more
detailed local alignments and scores. Substrings that yield too many (hundreds or
more) hits to the genome can be filtered out and ignored, or alignment time may
increase dramatically.
Sim4. Sim4 is one of the oldest and most frequently used programs for aligning
spliced DNA sequence with genomic sequence, allowing introns and a small number
of sequencing errors [FHZ+98]. Unlike BLAST, it attempts to recognize biological
valid splice sites for non-contiguous alignments to the genome. Sim4 was created
because of the inefficiency of BLAST when mapping large numbers of cDNA se-
quences to genomes. Researchers use Sim4 for studying gene-to-genome annotation
and alternative splicing. However, Sim4 can be slow since it uses dynamic program-
ming. Older EST alignment tools such as est genome [Mot97] and est2gen [GMP96]
also use dynamic programming, and too slow to search entire genomes.
Spidey. Spidey is a computer program to align spliced sequences to genomic se-
quences [WCO01]. It is incorporated in the NCBI Toolkit for biologists to study
gene annotation and alternative splicing. To find good alignments, Spidey uses
NCBI BLAST to produce a list of candidate alignments, then refines the alignments
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while considering splice sites.
Squall. Squall is a tool similar to BLAT, but especially designed to map ESTs to
genomes [OM02]. Squall uses lookup tables to quickly find candidate substrings (21
bases) within 300 bases of the beginning and end of each EST sequence. It improves
efficiency by discarding all candidates that map to more than ten locations in the
genome. If the distance between the start and stop candidates is less than 3 million
bases, a more precise algorithm is used to calculate and score possible EST to genome
alignments.
The authors claim Squall is 100 times faster than BLAT. However, we find
BLAT to be much faster than reported in their paper, indicating the authors may
have not filter out excessively common substrings from the BLAT hash index as
recommended. The authors report 0.03, 1.69, and 12 seconds to align each RefSeq
sequence to human chromosome 22 using Squall, BLAT, and sim4 on a PrimePower
1000. In comparison, for the same data set on a SunFire 6800 we found it takes
0.02, 0.054, and 31 seconds using ESTmapper, BLAT, and sim4.
GMAP. GMAP is a recently developed tool for mapping and aligning cDNA se-
quences to genomes ([WW05]). It achieves high precision and efficiency by using a
minimal sampling strategy for genomic mapping, starting with an index of 24-mers
(stored as a pair of 12-mers). Matching oligomers between cDNA and the genome
are chained together for approximate alignment, then dynamic programming (DP)
is performed from both ends of the cDNA (sandwich DP) for splice site detection. In
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addition, GMAP can attempt to identify microexons [VHS03] using statistical sig-
nificance testing. GMAP also requires less memory by keeping a very small lookup
table in memory and only reading in portions of the genome with high probability
of alignments. In experiments GMAP was able to identify splice sites more accu-
rately than BLAT, sim4, Spidey, and GeneSeqer for sets of human and Arabidopsis
cDNAs. GMAP also proved to be highly efficient, providing about a 6-fold speed
improvement over BLAT.
ESTmapper/sim4. We recently discovered another sequence alignment software
also called ESTmapper which we will refer to here as ESTmapper/sim4. It was de-
veloped by Florea and Walenz [FW] and is referenced elsewhere [ISF+04, FFM+05].
ESTmapper/sim4 is also a software package for aligning cDNA onto genomic se-
quences. It uses a k-mer based algorithm to pre-compute indices for each genome,
while we use suffix trees to pre-compute indices for each genome. ESTmapper/sim4
also couples with sim4 for generating spliced alignment results.
2.2.3 EST Clustering
Clustering is usually the first step in using ESTs for gene finding. Historically
clustering algorithms compare ESTs against each other to form clusters. NCBI also
maintains UniGene, a reference list of EST clusters automatically generated from
ESTs in dbEST [WBB+03].
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TGICL. TGICL (TIGR Gene Indices CLustering tools) is an example of a pop-
ular software system for clustering large EST data sets using pairwise compar-
isons [PHL+03]. TGICL uses mgBLAST, a modified version of megaBLAST that
provides additional output filtering and uses a dynamic offset within a database for
incremental searches. MgBLAST is used to quickly perform an all-to-all pairwise
comparisons between EST sequences. Processing can be performed in parallel by
partitioning the database, then merging compressed sorted files.
Clustering uses a greedy algorithm based on the best alignments, and known
full-length cDNAs can be used as seeds to improve efficiency and produce larger
clusters for incremental updates. Clusters output are passed to the CAP3 assembly
tool [HM99] as multi-FASTA files and then assembled into high-quality consensus
sequences. TGICL is used to generate the TIGR Gene Indices for 60 different species
with between 10 thousand and 4 million EST sequences [LHP+00]. TGICL has been
parallelized for PC clusters using PVM.
PaCE. PaCE (Parallel Clustering of ESTs) is one of the first clustering tools de-
signed to exploit the power of suffix trees to avoid the need for all-to-all pairwise
comparisons [KAKB03]. It first constructs (in parallel) a generalized suffix tree
consisting of all EST sequences by first sorting ESTs and sending each to the ap-
propriate processor. Once the suffix tree is complete, a variation of the algorithm
for finding longest repeated substrings can be used to find all pairs of ESTs with
common substrings above a certain threshold. The clustering algorithm then starts
with pairwise comparisons between ESTs with long common substrings, greatly
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increasing the likelihood of forming a cluster.
By using an on-demand algorithm for generating promising EST pairs, the
PaCE approach generally requires only O(n) number of pairwise comparisons, though
O(n2) are still needed in the worst case. Additional refinements are needed to create
and maintain clusters in parallel. Clusters produced by PaCE are of high quality
when compared to a benchmark EST set from Arabidopsis created by aligning ESTs
directly to the genome. A weakness of the PaCE system is that building a suffix
tree for the input EST data set requires a large amount of memory, proportional to
the number and size of ESTs. The authors were able ameliorate this problem by
parallelizing their algorithm to run on a PC cluster, splitting the suffix tree so that
each node only needs to hold a portion of the suffix tree in memory.
2.2.4 WOTD Suffix Tree
A suffix tree is a data structure that allows many problems on strings (se-
quences of characters) to be solved quickly and efficiently [Gus77]. It is formed by
calculating and storing all the suffixes of a string in a trie structure. Suffix trees
may be also compressed and compacted, storing entire substrings as indices to the
original string to reduce storage.
Suffix trees are very efficient data structures. They can be constructed in O(n)
time, and finding longest common substrings between two sequences and longest
repeated substrings only require O(n) time. Unfortunately, there is a large (30+)
multiplicative factor in the size of the suffix tree relative to the original sequence.
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Researchers have investigated different efficient implementations and algo-
rithms on suffix trees. One recently developed variation is called a write-only, top-
down (WOTD) suffix tree [GJS03]. WOTD suffix trees are more expensive to build
in that they require O(nlog(n)) expected and (O(n2)) worst time to construct, but
they require only a 10 to 12-fold increase in memory relative to the original sequence,
and display good cache locality in performing searches.
WOTD suffix tree implementations may be eager (build the full WOTD tree
immediately) or lazy (build portions of the WOTD tree as needed as queries are
processed). In our research, we used the eager version of the WOTD implementation
to avoid the expensive tree building overhead by building suffix trees once and
using them whenever we need to align cDNA sequences to genomes. For eager
implementation, the suffix tree is built starting from the root. The sub-trees are
built recursively following the order of from top to bottom. The built suffix tree are
stored in two flat arrays: root’s children table and suffix tree table. This property
of WOTD suffix tree makes it easy to build tree once and store the tree on the disk
to use later.
2.3 ESTmapper: Efficiently Aligning DNA Sequences to Genomes
The traditional hash table based algorithms (BLAST [BPC+99], Spidey [WCO01],
BLAT [Ken02], Sim4 [FHZ+98], etc.) usually return too many hits in the word
searching step, thus causing the algorithms to spend a long time selecting and stitch-
ing together hits in the following steps. To speed up cDNA to genome alignment,
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we designed ESTmapper [WLT05], our algorithm for aligning DNA sequences to
genomes based on WOTD suffix tree for indexing the genomes.
The principle behind ESTmapper algorithm is still based on local sequence
similarity. The assumption is that DNA sequences which can be mapped back
onto genome should share a high degree of local sequence similarity with some
specific area of genomic sequence, even considering introns and sequencing errors.
The advantage of ESTmapper (in addition to fast substring search speed) is that
the algorithm can filter out most short common substrings shared between DNA
sequence and genome sequence, and only deal with a very small number of long
common substrings that lead to high quality alignments. As a result, ESTmapper
can process the sequences much faster than other algorithms, but hopefully without
sacrificing the precision of the results.
2.3.1 Algorithm
The algorithm used by ESTmapper consists of the following steps:
Preprocess the genome. The genome sequence is read from a file and converted
into a eager WOTD suffix tree. Preprocessing the genome only needs to take place
once per genome, since the eager WOTD suffix tree can be stored as two flat arrays
(root’s children table and suffix tree table). The root’s children table has a fixed
maximum size, and suffix tree table has variable size. So after the suffix tree is built
for each genome, the root’s children table, suffix tree table size and the actual suffix
tree table are written out to disk as a single file. When ESTmapper needs to use
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the genome suffix tree, the two tables can be quickly read back into memory in the
order they are stored on the disk.
Map DNA sequences to the genome. Each DNA sequence is mapped using the
suffix trees for the genome, considering both its minus and plus strand. Mappings
are computed as follows:
1. Find long common substrings
Suffixes of each EST sequence are compared to the suffix tree for the genome
to find long common substrings. Performance is improved in several ways.
First, we discard common substrings that are below a user-specified minimal
length, or that appear too often in the genome according to a user-specified
frequency threshold. This step limits the number of random matches for the
same common substrings, and reduces the need to examine common substrings
that probably lead to low-quality alignments.
Second, we avoid checking all suffixes of each EST sequence, by skipping past
suffixes where possible. Skipping means the next long common string search
will start from the current starting matching position plus a skip offset. The
WOTD suffix tree does not maintain suffix links in order to reduce storage, so
we do not know the ideal skip offset. Instead, we choose either the length of
the current common substring on the query EST sequence, or a user-specified
skip offset, whichever is greater. Since we extend common substrings in the
next step, we do not need to find the longest common substring, just one long
enough to be extended.
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When the search is completed, the long common substring lengths and loca-
tions on both DNA and genome sequence are stored for next step of processing.
We expect such long common substrings to be common, since the query EST
sequence was most likely expressed by the genome in the first place.
2. Extend long common substrings
Each long common substring found in the first step is extended in both di-
rections. This substring extension step is similar to NCBI BLASTN’s match
extension step except ESTmapper’s extension is based on long common sub-
strings instead of matched k-mers. Then the extended substrings are sorted
in order of their locations.
3. Build (spliced/gapped) mappings
To handle splicing and gaps, the ESTmapper algorithm examines the list of
long substrings and locations, and combines them into a single spliced/gapped
mapping region if two substrings’ mapping location on genome are sufficiently
close to each other.
4. Refine the mappings/alignments
ESTmapper looks through the mappings’ component substrings to determine
whether two substrings are close enough on both DNA and genome sequence
that they can be merged into one with small gaps and/or mismatches in be-
tween. After the check, each substring should correspondent to one exon.
Boundaries of substrings are then adjusted so that they abut good splice
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donor and acceptor sites. Splice sites are also chosen in ways designed to
avoid changes to the alignment.
Choose the best mappings. In the final step of the algorithm, each mapping will be
assigned a score based on match reward, mismatch and gap penalties. The E-value
is calculated based on [AG96] and [KA93]. The best mapping(s) will be selected
based on the E-values for each DNA sequence.
The full algorithm used by ESTmapper is presented in Figure 2.1.
2.3.2 Mapping Statistics
As a metric for the accuracy of mapping results, most current DNA mapping
algorithms [FHZ+98, Ken02, WCO01] simply report the percentage identity and
coverage percentage for each mapping. As far as we know, current tools do not
provide statistical significance estimates for mapping results similar to E-values
produced by pairwise sequence alignment algorithms such as BLAST.
With only percentage identity and coverage percentages, it is difficult to dis-
tinguish two mappings with the same percentage identity and coverage percent-
ages, but with different intron size (on genome) and gap size (on DNA sequence),
both of which are very important for selecting the best mapping(s) since the best
mappings tend to have the smallest intron size and gap size. To provide accurate
mapping results, in ESTmapper we borrow and modify the “sum statistics” theory
[AG96, KA93] from BLAST to assign an E-value for each mapping. We then use
these to compare mappings and select the best mapping with the E-value as the
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// preprocess genome
for each (subset) genome sequence
build & store suffix tree T
// map DNA sequence
for each (subset) genome (if genome is partitioned)
{
load suffix tree T
// find long common substrings and
// build spliced/gapped matching regions
for each DNA sequence E
{
// examine suffixes of E
while offset F < length(E)
for suffix of E beginning at offset F,
find longest common substring S in T
if length of S >= MIN_MATCH_SUBSTRING and
frequency of S in genome <= MAX_MATCH_FREQ
store S & its location in T
increase offset F by MAX(length(S), MIN_SKIP)
// extend long common substrings
for each S
extend it in both directions
// build spliced/gapped mappings
for all S
examine locations of S1, S2
if S1 near S2 with gap G <= MAX_GAP
form/extend matching region M for S1,S2
form mapping MAP based on M
// refine mappings
for each MAP
refine mapping considering gaps and splice sites
calculate alignment score and E-value
assign to E the MAP with the smallest E-value
}
}
find and output each DNA’s best mapping location(s)
}
Figure 2.1: ESTmapper Algorithm
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final output DNA-to-genome alignment.
According to [AG96], the optimal scores from ungapped local alignments follow
an extreme value distribution. The probability that the optimal ungapped local
alignment has a score S of at least x is:
P (S ≥ x) = 1 − exp(−Kmne−λx) (2.1)
where K is a constant given by a geometrically convergent series depending on score
matrix and the probabilities of varies amino acid/nucleotide types, m is the number
of letters in query sequence, n is the number of letters in database sequence(s) and
λ is a positive scalar to convert the alignment raw score to a normalized score. The
number of alignments expected by chance (E) during a sequence database search
can then be estimated by:
E = Kmne−λS (2.2)
These equations can also be extended to scoring gapped local alignments.
However, equations 2.1 and 2.2 only apply to the single highest score region of
the sequence. When mapping DNA sequences to genome sequence, there are usually
several high score regions because of the exon/intron structure in genome sequence.
Under this condition, it is necessary to assess the combined statistics of multiple




(λSi) − ln (Kmn) −
(r − 1)(ln (K) + ln (G) + ln (g)) − log (r!) (2.3)
where G is the largest intron size in genome and g is the largest gap size in DNA
sequence. ESTmapper calculated Si for each extended long “common” substring
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based on BLAST like local alignment score with match reward as 1, mismatch
penalty as −3, gap opening penalty as −10 and gap extension penalty as −5. Then








To obtain the tail probability for Tr ≥ x, ESTmapper will integrate f(t) for t from
x to infinity with the function from NCBI BLAST:
Pr(S ≥ x) =
rr−2









Usually, P ′r(S ≥ x) = Pr(S ≥ x)/β
(r−1)(1−β) is used instead of Pr(S ≥ x) to correct
the results for the statistic significance test. This is because only if Pr(S ≥ x) is
less than P (S ≥ x) of any component high score region, these r region alignment
is the optimal alignment and can be used to replace the P value of single highest
score region. However, for mapping DNA sequence to genome sequence, since all
the found exons should be part of the alignment, the correction function is not
necessary. The final E value is calculated by E = − ln(1 − Pr). ESTmapper uses
this E value to select the best mapping result.
Note that though we found it useful in ESTmapper to utilize both BLAST’s
statistical model for scoring matches and BLASTN’s match extension algorithm for
extending long common substrings, the underlying biological model for BLAST (ho-
mology, mutations) and ESTmapper (expressed DNA, splicing, sequencing errors)
are different. We have been fortunate in that the two models are sufficiently similar
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that ESTmapper appears to perform well in practice. It would be interesting to
see whether adjusting both algorithms to DNA-to-genome mappings would improve
mapping precision.
2.3.3 Implementation
ESTmapper is written in C and implemented on top of the WOTD suffix tree
software (version 1.1) implemented by Stefan Kurtz [GJS03]. The WOTD suffix tree
implementation was downloaded from http://bibiserv.techfak.uni-bielefeld.
de/download/tools/Wotd_11.html. The WOTD suffix tree source code was mod-
ified and used as our main data structure for storing and indexing genomes.
2.3.4 Parallelization
Being able to exploit the power of parallel computing is a major advantage
for computationally intensive applications such as mapping large number of DNA
sequences onto genomes. It turns out that the ESTmapper algorithm, like many
problems in computational biology, is embarrassingly parallel and can be easily par-
allelized at a coarse-grain level for efficient parallel execution. The parallel versions
of ESTmapper work as follows.
2.3.4.1 Multithreaded ESTmapper
On shared-memory multiprocessors (SMPs) ESTmapper may be parallelized
according to the master-worker parallel paradigm using pthreads. The master thread
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first reads the suffix tree of the genome into memory sequentially. Next, the master
thread spawns workers (pthreads) and assigns DNA sequences to each worker to
find mappings. When all sequences have been mapped to the genome, the master
thread collects and outputs the result.
Load balancing is simple since the bulk of the computation is mapping DNA
sequences to the genome, and the mapping time is usually proportional to the num-
ber of bases being mapped. So the master thread just needs to assign roughly the
same number of bases to each thread to ensure an even division of work.
2.3.4.2 Message-passing ESTmapper
On message-passing machines such as PC clusters, ESTmapper may be paral-
lelized using the MPI communications library to communicate between processors.
To reduce communication costs, each processor reads the suffix tree into memory in-
dependently. The master node assigns and sends DNA sequences each node. Every
node then finds genome mappings for its sequences locally, without any need for in-
terprocessor communication. Once mappings are computed for assigned sequences,
each node sends its mappings to the master node to be collected and output.
ESTmapper is very efficient on clusters, since little communication is needed,
just at the beginning and end of the overall computation to send out DNA sequences
and retrieve their mappings. Performance can be improved further if each node




To evaluate ESTmapper, we compared its performance and precision with
other mapping and clustering algorithms. We downloaded and installed the latest
versions of BLAT, Sim4, Spidey, TGICL, PaCE, and the NCBI BLAST software
suite and toolkit on a Sun SunFire 6800 SMP with 24 processors (UltraSparc III
750Mhz) and 72 GB memory. For message-passing speedups we also ran ESTmapper
on a Linux PC cluster with 1.6 GHz AMD Athlon processors and 1 GB memory per
node.
For test data, we downloaded EST, gene, and genome sequences for Arabidop-
sis Thaliana (mustard plant) and Homo Sapiens (human) from NCBI, UCSC genome
browser and Sanger Institute. The Arabidopsis genome is about 115 million bases,
and the Human genome is about 3 billion bases. The EST and gene DNA sequences
we use were chosen because they were previously mapped to the genome by biolo-
gists (or put in widely accepted clusters). We can thus used them to evaluate the
precision of mapping and clustering algorithms used by ESTmapper and other tools.
Three data sets used in many of our experiments are:
• DataSet1: 263, 255 EST and cDNA sequences (average length 734 bases) from
Arabidopsis UniGene build #44 from NCBI
• DataSet2: 28, 952 Arabidopsis genes (average length 1322 bases) and 5 Ara-
bidopsis chromosomes from NCBI.
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• DataSet3: 936 Human genes (average length 1936 bases) mapped to chromo-
some 22 and Build #30 of Human chromosome 22 from Sanger Institute.
• DataSet4: 1, 383, 818 Human EST sequences (average length 686 bases) and
Human genome Build #35 from NCBI.
2.4.2 Mapping Parameters
ESTmapper requires users to input basic mapping parameters. The default
value for minimum common substring length is 25 bases, for maximum number of
mapping locations is 30, for maximum human intron size is 500,000, for maximum
Arabidopsis intron size is 6000, skip step size is 10.
2.4.3 Basic Performance
We begin by examining the time and memory required by ESTmapper with
respect to suffix trees and multiple processors. WOTD suffix trees can be more
expensive to build than other suffix trees in that they require O(nlog(n)) expected
and O(n2) worst time to construct. However, they can yield good performance for
substring searches because the WOTD data structures provide good cache locality.
Since the WOTD suffix tree is stored in a flat array, users can also build the suffix
tree once and store it on disk for later use.
When constructing a WOTD suffix tree for the genome, we need to select
the number of trees we plan to use. ESTmapper can build a single suffix tree for
the entire genome (by concatenating the DNA sequence of each chromosome), one
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tree per chromosome, or any number of trees (by first concatenating, then splitting
the DNA sequences of all chromosomes). Some additional bookkeeping is required
to keep track of the original chromosomal locations of each sequence. When the
genome is partitioned into multiple suffix trees, ESTmapper can iteratively compare
nucleotide sequences against each suffix tree, record the mappings found, and select
the best overall mapping at the end.
Figure 2.2a shows the result of using multiple suffix trees to map Arabidopsis
ESTs from DataSet1 to the entire genome. We find ESTmapper runs faster with
fewer suffix trees, but trees are larger and require more memory. We thus have a
classic memory/speed tradeoff in choosing how to use ESTmapper. Choosing the
proper number of trees to use depends on the available memory. If insufficient
memory is available to hold the suffix tree for the entire genome, ESTmapper can
reduce its memory usage at the expense of longer running times by partitioning the
genome and building separate suffix trees for each portion of the genome.
Figure 2.2b shows the performance of multithreaded ESTmapper on the Sun-
Fire 6800 SMP and message-passing ESTmapper on a Linux PC cluster when map-
ping DataSet1 to the entire Arabidopsis genome. We find that ESTmapper obtains
fairly good 8-processor speedup for the SMP (6.9) and PC cluster (5.7).
We believe speedups are lower on the PC cluster because (sequential) file I/O
to load suffix trees is both slower (44 seconds on PC cluster, versus 14 seconds on
SMP), and takes up a larger portion of total execution time on the faster PCs (186
ESTs mapped/second on PC nodes, versus 83 ESTs mapped/second on the SMP).
If the file I/O time is eliminated, ESTmapper achieves a 8-processor speedup of 7.5
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on the SMP and 8.0 on the PC cluster. We thus expect ESTmapper speedups to
improve for larger input data sets, where file I/O is less important. Memory use
remains constant for ESTmapper relative to the number of processors, since each
processor maintains a local copy of the suffix tree.
2.4.4 Genome Mapping Performance Comparison
The performance of six DNA-to-genome alignment tools (ESTmapper, BLAT,
Sim4, Spidey, BLAST and megaBLAST) were evaluated with Arabidopsis and Hu-
man data. We mapped 936 Arabidopsis genes from DataSet2 onto chromosome I,
and 936 Human genes in DataSet3 onto chromosome 22. All tools were run sequen-
tially on a single processor of the SunFire 6800. Running times are shown in Figure
2.2c. “ESTmap” stands for ESTmapper and “megaB” stands for megaBLAST. Note
that running times are presented using log scale along the Y-axis.
Results show that ESTmapper is the fastest among six evaluated software
tools, and has reasonable memory usage. It is about 3–6 times as fast as BLAT, 21–
45 times as fast as megaBLAST, 1000 times as fast as Spidey and 4000 times faster
than Sim4. These results seem reasonable when we remember that only ESTmapper
and BLAT preprocess the genome to improve performance. ESTmapper is likely
more efficient than BLAT because it is able to find the longest common substrings
directly, rather than extending hits.
Figure 2.2d presents the memory used by each of the alignment tools. We







































































































































































Figure 2.2: Performance Comparison of EST Mapping and Clustering Algorithms
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memory. ESTmapper requires about 4 times more memory than BLAT.
2.4.5 Genome Mapping Precision Comparison
Next, we compared the precision of the DNA-to-genome mappings found by
four tools (ESTmapper, BLAT, Sim4, Spidey) for all 28, 952 Arabidopsis genes and
936 Human genes from DataSet2 and DataSet3. We used the Arabidopsis gene
annotation information provided by biologists at TIGR and Human gene annotations
from biologists at Sanger Institute as the correct mapping. Results about percentage
of correctly mapped individual nucleotides, complete exons and genes are shown in
Tables 2.1, 2.2 and 2.3.
Results show that Sim4 is the most precise mapping software, on both nu-
cleotide level and exon level, and for both Arabidopsis sequences and Human se-
quences. On gene level, BLAT is most precise for Arabidopsis data (95.4% correct)
and Sim4 is most precise for Human data (94.8% correct). So overall, for human
sequences, Sim4 provides the best accuracy rate. ESTmapper is close behind, while
BLAT and Spidey lag (< 90% correct on three levels).
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Spidey BLAT Sim4 ESTmapper
Arabidopsis 99.6% 97.3% 99.7% 99.4%
Human 80.5% 82.9% 99.9% 98.6%
Table 2.1: Precision Comparison with 36,298,530 Arabidopsis Nucleotides and 1,811,944
Human Nucleotides
Spidey BLAT Sim4 ESTmapper
Arabidopsis 97.8% 97.0% 97.7% 96.1%
Human 86.6% 84.8% 98.0% 95.4%
Table 2.2: Precision Comparison with 155,970 Arabidopsis Exons and 5,176 Human Exons
Spidey BLAT Sim4 ESTmapper
Arabidopsis 94.6% 95.4% 94.3% 90.6%
Human 87.4% 86.3% 94.8% 91.8%
Table 2.3: Precision Comparison with 28,952 Arabidopsis Genes and 936 Human Genes
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Chromosome # # of ESTs on chromosome ESTmapper BLAT
1 130,366 94.9% 90.3%
2 86,773 97.5% 92.4%
3 71,532 95.1% 91.8%
4 49,292 94.8% 95.1%
5 59.857 98.0% 92.9%
6 83,144 95.8% 89.9%
7 67,656 88.5% 41.8%
8 46,542 96.6% 93.5%
9 52,959 97.5% 92.7%
10 45,973 98.0% 93.1%
11 91,849 96.6% 93.7%
12 98,265 95.6% 96.5%
13 19,404 97.3% 93.0%
14 45,299 97.1% 93.0%
15 45,948 94.8% 91.9%
16 54,449 96.2% 91.6%
17 94,430 95.7% 87.1%
18 17,966 98.2% 91.7%
19 89,527 96.2% 92.0%
20 37,647 98.5% 95.7%
21 12,155 95.8% 92.7%
22 39,816 96.9% 92.3%
X 40,175 95.6% 92.8%
Y 2,794 97.7% 94.3%
Total 1,383,818 95.9% 89.1%
Table 2.4: Precision Comparison with 1.4 million Human ESTs by Chromosome
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There is only one Human gene ESTmapper mapped incorrectly because there
is one exon which is too small to be found with the default ESTmapper settings.
Most such small exons can be found by ESTmapper with a finer grain search, at the
cost of reduced processing speed. Fortunately, very small exons usually do not occur
often in large genomes [DL99, SCK04]. For Arabidopsis sequences, Sim4 and BLAT
are the most precise. ESTmapper provides the similar accuracy rate on nucleotide
level, very close on exon level (∼ 1% difference) and not far behind on gene level
(∼ 4% difference).
To further analyze precision of ESTmapper’s mapping results, we compared
ESTmapper and BLAT’s mapping results on gene/EST level for all 1.4 million
human EST sequences from DataSet4. The annotation information for these ESTs
are obtained from NCBI Mapview database. We only used BLAT for comparison
because of the processing speed limitation of other tools. Results are shown in
Table 2.4. We find ESTmapper correctly mapped 96% of the 1.4 million ESTs to
the human genome, while BLAT correctly mapped 89% of the ESTs, a difference
of 94, 350 sequences. It seems ESTmapper has better precision than BLAT when
mapping human ESTs.
While the precision of EST alignment is similar for most chromosomes, it is
very different for chromosome 7. One possibility is that it has some very large
introns, so it is hard for either tool to map all of the exons on the same EST
sequence to the chromosome. Another possibility is that chromosome 7 has some
unusual splicing motifs not found elsewhere, so it is difficult for either tool to detect
exact exon boundaries. In either case ESTmapper still performs better than BLAT.
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2.4.6 EST Clustering Performance Comparison
Next, we compared the performance and precision of using genome mappings
to cluster ESTs against other clustering algorithms such as PaCE and TGICL. We
form EST clusters out of all ESTs mapped to nearby or overlapping locations in the
genome. For the comparison, we used genome mappings from ESTmapper, Spidey
and BLAT.
In Figure 2.2e, we compared ESTmapper performance with TGICL and PaCE
for 190,740 Arabidopsis ESTs mapped to the Arabidopsis genome preprocessed as a
single suffix tree. All three tools were timed using 8 processors on the SunFire 6800.
Note that running time is displayed in log scale along the Y-axis. We discover that
ESTmapper is significantly faster for large numbers of ESTs. Figure 2.2f shows the
performance of BLAT, Spidey, and megaBLAST when used to cluster ESTs using
one processor on the SunFire 6800. Due to the slow processing speed of Spidey and
high memory usage of megaBLAST, for the second set of experiment we were only
able to use 15,293 EST sequences. We note once again that ESTmapper is the most
efficient clustering algorithm.
We also found ESTmapper has almost constant memory usage of about 1 GB.
In comparison, memory usage for PaCE and megaBLAST increases very quickly
as the number of ESTs increases. PaCE used 1.4 GB memory on each processor
when processing 190, 740 sequences. megaBLAST used about 4 GB memory when
processing 15, 293 sequences and ran out of memory when the number of ESTs was
increased.
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2.4.7 EST Clustering Precision Comparison
To compare the precision of the clusters produced by the different algorithms,
we used BLAT, Spidey, PaCE, TGICL and ESTmapper to cluster ESTs from Ara-
bidopsis UniGene build #44 in DataSet1. Because of the memory limitation with
PaCE and speed limitation with Spidey, we only used the 15, 293 EST sequences
from the first 1000 Arabidopsis clusters in UniGene. We measured the percentage
of clusters exactly matching UniGene, the number of clusters produced by each al-
gorithm, and the number of singleton clusters (with a single EST). The results are
shown in Table 2.5.
Spidey BLAT TGICL PaCE ESTm.
% identical 80.5% 81.4% 72.6% 60.5% 97.1%
# clusters 930 1152 1006 1575 1006
# singletons – 101 296 573 9
Table 2.5: Precision Comparison with 1000 Arabidopsis UniGene Clusters
Again, ESTmapper produced clusters that are most similar (97%) to UniGene
clusters. The other clustering techniques based on mapping ESTs to the genome
were next (80%), while EST-only techniques produced significantly different clus-
ters. ESTmapper also produced the smallest number of singletons clusters when
compared to other algorithms. In addition to the results in Table 2.5, we also have
clustering comparisons results for TGICL, BLAT and ESTmapper using the total

























Figure 2.3: Clustering 5.5 × 106 Human ESTs
53.8% exactly matched clusters, BLAT found 66.5% exactly matched clusters, and
ESTmapper found 83.6% exactly matched clusters. Though all three algorithms
are less precise for the full set of Arabidopsis UniGene clusters, ESTmapper still
provides the results closest to UniGene.
2.4.8 Scalability
Finally, to evaluate the scalability of ESTmapper, we also measured the com-
putation time and memory usage of ESTmapper when used (on a SunFire 6800
with 8 processors) to cluster all 5.5 million human EST sequences by mapping them
against the human genome (Build 35). To reduce memory use, the genome was split
into 30 equal-sized pieces requiring about 1 GB suffix trees for each piece. Results
are shown in Figure 2.3. ESTmapper was able to cluster all ESTs in 10.8 hours
(0.056 seconds per EST for each processor), with the processing time increasing
fairly linearly with the number of ESTs. Performance can be improved by using
more memory and fewer trees.
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2.4.9 Discussion
Our experimental evaluation of ESTmapper shows it is quite efficient and
precise when compared with other sequence alignment techniques such as BLAT.
For the purpose of EST clustering, ESTmapper also performed very well compared
to other clustering algorithms.
2.5 Conclusion
Our experimental evaluation of ESTmapper shows it is quite efficient and
precise when compared with other sequence alignment techniques such as BLAT.
The only disadvantage is that ESTmapper requires more memory and disk storage
to hold and store the suffix tree needed for the genome. Fortunately the amount of
memory and disk space available in computers is quickly increasing while genome
size stays constant, so memory use should become less of an issue as time goes on.
For the purpose of EST clustering, ESTmapper also performed very well compared
to other clustering algorithms. The main disadvantage here is that ESTmapper can
only be used to cluster ESTs for organisms with sequenced genomes. As a result




Mass Spectrometry Based Peptide Identification
3.1 Background
Mass spectrometry (MS) is an analytical technique used to identify chemical
composition of the sample. More recently, with the advance of high throughput
equipment design, it has been used to identify protein content of biological samples.
Tandem mass spectrometry technique (MS/MS), when used in conjunction with
liquid chromatography (LC), can quickly determine the protein content of biological
samples in wide variety of context.
Since automated high-throughput mass spectrometry equipment can generate
huge amount of mass spectra data on a daily basis, analyzing results using efficient
and precise computer tools becomes an important step in mass spectrometry based
peptide identification. Despite presence of large amounts of noise in mass spec-
tra data, researchers have successfully used many different statistical models and
computer algorithms to improve peptide identification accuracy.
3.1.1 Mass Spectrometry
Mass spectrometers work by splitting biological samples into collections of
charged gas particles (ions) with different mass/charge ratios, then measuring their
relative abundance by magnetically accelerating the ions and sending them to a
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detector. Information on the mass of all ions detected can then be used to identify
the chemical composition of the original sample.
In tandem mass spectrometry, ions are fragmented using techniques such as
collision-induced-disassociation (CID), which shoots ions at high speed through a
cloud of inert gas particles. The ions resulting from collisions are fragments of the
original (precursor) peptide fragment, and can be used to identify its amino acid
sequence.
The peptide fragmentation pattern usually depends on the physical and chemi-
cal properties of the peptide sequence. Because the CO-NH bonds connecting amino
acids are weak, they tend to break most frequently when a peptide is fragmented.
Ions containing the N-terminus are known as bi ions, where i indicates the number
of amino acids composing the ion. Similarly, fragments containing the C-terminus
are labeled as yi ions.
Almost all peptide identification algorithms rely heavily on identifying b and y
ions in mass spectra. Other types of ions may also be created during fragmentation
(a and x ions if the CH-CO bond is broken, c and z ions if the NH-CH bond is
broken), but with much lower probability since those bonds are stronger than the
CO-NH bond.
The mass spectrometer measures the mass-to-charge ratio (m/z) of ionized gas
phase molecules. When the input are protein molecules, peptides are ionized and
their m/z values measured. The measured m/z values of the peptide fragment ions
form the so called tandem mass spectrum of the peptide, as shown in Figure 3.1.
In the figure, the x-axis is the mass/charge ratio of the ions and the y-axis is the
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intensity of the ions (number of particles detected).
Figure 3.1: Mass Spectrum
In a high-throughput setting, a complex mixture of unknown proteins are
cut into short amino acid sequences (peptides) using a digestion enzyme such as
trypsin; fractionated into reduced complexity samples on the basis of some physical
or chemical property such as hydrophobicity; and then a tandem mass spectrum
is taken for selected observed peptides in each fraction. The end result of such an
experiment is a set of a few hundred to a few thousand tandem mass spectra, each
of which represents a peptide of about 6-20 amino acid residues. Typically, amino
acid sequences of 8-10 residues carry sufficient information to determine the protein
from which the peptide is derived. This experimental protocol can reliably identify
hundreds of proteins from a complex mixture in several hours of instrument time.
3.1.2 Computer Algorithms for Peptide Identification
With recent developments in peptide identification algorithms, the mass spec-
tra interpretation process has been automated. Now the effectiveness of mass spec-
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trometry is determined by the ability of software tools to correctly identify peptides.
There are three main classes of software algorithms for mass spectra based peptide
identification. The first class of algorithms are designed to identify peptides and
proteins through protein database searches. The second class of algorithms are de-
signed to identify peptides and proteins using de novo sequencing techniques. The
third class of algorithms are designed to detect peptide through spectral matching.
3.1.2.1 Database Search Based Peptide Identification
The most popular approach for identifying peptides using mass spectra is based
on searching protein databases. Sequence database search algorithms [YECB96,
PPCC99, CB04, GMK+04, TSF+05] use protein sequence databases to suggest pep-
tide candidates for each spectrum. The peptide identification algorithms in category
generally follow three steps to identify peptides.
The first step is to computationally digest protein sequences with specific en-
zymes. In another word, the peptide identification algorithms predict what peptides
can be produced if the protein is entirely or partially digested by an enzyme. Then
the mass of the peptides are computed and compared with the spectrum mass. Only
those peptides whose mass falls within specified mass tolerance are selected as can-
didate peptides for the next algorithmic step. In the second step, the algorithms
create a hypothetical spectrum for each peptide candidate by predicting the peptide
fragmentation pattern and computing the masses of the fragments. The third step
is to compare the experimental spectrum with the list of hypothetical spectra.
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The algorithms use different match metrics (such as number of matched peaks,
number of matched ions, mass difference, etc.) to measure the similarity between
experimental spectrum and hypothetical spectrum. A score is generated to sum-
merize the comparison results. For each experimental spectrum, a list of potential
peptides are ranked according their scores. The highest score peptide is usually
considered as the one that matches the experimental spectrum most closely. The
database search based peptide identification approach has been very successful in
practice.
SEQUEST [YECB96] is one of the first algorithms to identify proteins by
correlating peptide tandem mass spectrum with amino acid sequence in protein
database. It constructs the hypothetical spectra by predicting the mass-charge
ratio of the fragment ions. The relative intensity of the ions is assigned according to
authors’ empirical knowledge of the appearance of tandem mass spectra for peptides.
For mass-charge ratios that represent b ion or y ion, it assigns a magnitude of
50.0; for mass-charge ratios that are within 1 distance to b or y ions, it assigns a
magnitude of 25.0; for mass-charge ratio that represent neutral losses of ammonia,
water, carbon monoxide and those within 1 distance, it assigns a magnitude of 10.0.
It then compares the experimental mass spectrum with hypothetical spectrum based
on a cross-correlation function between the two spectra.
Mascot [PPCC99], developed by Perkins et al., is one of the most widely used
protein identification softwares. It is based on MOWSE [PHB93] algorithm with
addition of probability based scoring. MOWSE algorithm considers the relative
frequency of a peptide with a given molecular weight being within a protein that
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falls in a given range of molecular weights. Mascot algorithm is based on MOWSE, it
uses additional probability-based score. The details of the algorithm are not released
to the public. But the authors claim the absolute score is the probability that a
match between experimental spectrum and peptide is a random event. To avoid the
confusion when directly reporting absolute probability score, Mascot reports the
scores as −10 log10(P ), where P is the absolute probability score.
OMSSA [GMK+04] is a probability-based protein identification method from
NCBI. After selecting the peptide candidates, it calculates a score based on the
statistic significance of a match. The basic assumption used by OMSSA is that
the number of product ion matches follows a Poisson distribution. It calculates an
E-value based on the number of random matches against N theoretical spectra.
X!Tandem [CB04] is a multi-step algorithm for quick peptide identification
from mass spectra. It filters out sequence candidates in multiple searching steps,
while considering more stringent searching criteria in each step. The central as-
sumption used by X!Tandem to improve the performance of filtering is that for each
identifiable protein, there is at least one detectable tryptic peptide. It can thus use
a quick match algorithm to look for fully digested tryptic peptides, and then look
for a more comprehensive list of peptides using heuristics limited to the proteins
where at least one match has been found.
The score function used by X!Tandem is based on a hypergeometric distribu-
tion calculated as the dot product of the intensities of the matching ions, multiplied
by the factorials of the number of matched b and y ions. The E-value calculated by
X!Tandem is based on just how unlikely a greater hyperscore is to be found, based
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on statistical analysis of current hyperscores.
InsPecT [TSF+05] is an algorithm that performs high-throughput identifi-
cation of peptide mass spectra. Its emphasis is on efficiently identifying post-
translational modifications and mutations with high confidence. It uses peptide
sequence tags as filters to select a small number of database sequences that contain
the peptide which produced experimental spectrum with very high probability. In-
sPecT is able to search a broad range of post-translational modifications efficiently
by searching within the largely reduced search space.
PepHMM [WYC06] is an algorithm that uses HMMs for peptide identification.
It builds a HMM to capture the correlation among matched and unmatched ions to
improve the precision of peptide identification.The proposed HMM can be used as a
general post-process model for any experimental spectrum to theoretical spectrum
matching scheme. Once trained, HMM can be used to reassess spectra comparison
results.
One weakness of database search engines is that they do not fully use peak
intensity information in the mass spectra when computing scores. An even greater
flaw of database search based peptide identification is that the results are limited to
known protein sequences in the database. It is thus impossible to identify new pro-
tein sequences using database search engines. Researchers are trying to compensate
this by incorporating six-frame translation of nucleotide sequences (EST, SNP, etc.)
into the protein sequence search space. An alternative relies on de novo sequencing.
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3.1.2.2 De Novo Sequencing
De novo peptide identification algorithms [DAC+99, BE03, CKT+01, MZL+03,
TJ97] attempt to determine the peptide sequence using only the peptide fragment
information of the tandem mass spectrum. Candidate peptides are generated with-
out using protein sequence databases. The typical de novo algorithms starts by
creating a spectrum graph for each experimental spectrum after filtering the noise
peaks. The spectrum graph is a graph representation of experimental spectrum.
The application of graph theory in de novo sequencing was first proposed by
Bartels [Bar90]. In the spectrum graph, each peak in the experimental spectrum is
represented as a vertex (or several vertices). The algorithms connect two vertices
with an edge if the mass difference between two vertices equals the mass of an amino
acid (within some mass tolerance). The edge is then labeled with the name of the
amino acid. The weight of the edge is given by a score function that measures the
mass difference between the theoretical mass and the experimental mass of the edge.
Using the de novo approach, the problem of peptide identification then be-
comes the problem of finding the longest path in the spectrum graph. Some al-
gorithms also use spectrum graphs to generate possible peptide sequences. The
peptide sequences set is extended and trimmed in an iterative procedure based on
the design of the algorithm. A different class of algorithms use score functions to
optimize over the space of possible peptide sequences.
Researchers in the field use graph theoretic algorithms, Markov chain Monte
Carlo heuristic optimization, or HMMs to perform de novo peptide identification.
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The advantage of de novo algorithms is that it works without requiring known
protein sequences. De novo algorithms can thus be used to discover novel peptides.
Tools such as GutenTag [TSY03] demonstrate other advantages of de novo
algorithms. First, by accounting for mass differences between vertices due to post-
translational modifications (PTMs), de novo algorithms can detect many PTMs in
a computationally efficient way. Second, de novo algorithms may be able to detect
very short peptide sequences (tags) with high confidence, even if the entire peptide
sequence cannot be determined, providing useful information to complement other
peptide identification methods.
A weakness of de novo sequencing is that the percentage of spectra in a data set
that can be identified conclusively using novo analysis is usually quite low, because
tandem mass spectra often do not contain enough fragments to draw unambiguous
conclusions. As a result, de novo peptide identification techniques only work well
with high quality mass spectra. In addition, since the observed peptide sequences
represent only a small portion of possible amino acid sequences, de novo interpreta-
tions typically produce a long list of equally possible peptide sequences.
Some researchers have proposed methods that combine both de novo sequenc-
ing techniques and a database search based peptide identification strategy. Mann et
al. use a sequence tag of three or so amino acids derived directly from the tandem
mass spectrum to search a protein sequence database [MW94]. This approach has




The spectral matching approach identifies peptides by comparing new exper-
imental mass spectra with a reference mass spectra library. The mass spectra li-
brary is built with previously observed and identified spectra. Spectra in the library
usually represent a consensus of several experimental mass spectra that have been
identified and mapped to the same known peptide. Spectral matching is different
from both database search based and de novo sequencing methods in that it makes
no attempt at predicting the unknown spectra. Instead, it compares the unknown
spectra with library spectra – the observed spectra consensus.
One advantage of spectral matching approach is it can use more information in
each mass spectrum, such as the peak intensity information observed in previously
identified spectra. In comparison, both database search based and de novo sequenc-
ing peptide identification algorithms usually consider peak intensity to be a minor
factor when matching experimental spectrum with hypothetical spectrum generated
from protein sequence. One reason is the unpredictability of the peak intensity. The
unknown ion types, missing ions, noise, isotopic ions and machine errors all make
peak intensity vary from run to run. However, with identified spectra, it is much
easier to use peak intensity, which can contains important information about the
peptide sequence.
With both ion mass and peak intensity information, spectral matching may
be able to make peptide identifications with higher confidence than by using mass
alone. Under some circumstances, a spectrum with only a few peaks can be strongly
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identified because of the fragmentation characteristic of that peptide. In contrast,
a small number of peaks can only provide very limited information for traditional
database search based methods to disambiguate similar peptide sequences.
Traditional spectral matching approaches use a library of spectra and a spec-
tral similarity measure to evaluate the quality of the spectrum-spectrum match
[Ste94, SS94, Ste95]. Library spectra can be real spectra, identified using traditional
sequence database search tools, or consensus spectra that summarize the most im-
portant features of spectra from a particular peptide. Spectral comparison functions
have traditionally been based on the dot-product of a vectorized representation of
each spectrum.
Recently, a number of groups have described spectral libraries of high-quality
real spectra with high-confidence identifications [YMG+98, JCL+06, FMW+06, LDE+07]
and consensus spectra [SKN+06, LDE+06, CCFB06]. Results indicate spectral
matching can be both precise and efficient, identifying many spectra missed database
search based algorithms. NIST’s MS Search software [MSS05] is a dot-product based
spectral matching search engine, it searches libraries of peptide fragmentation spec-
tra [SKN+06] to identify unknown mass spectra.
However, the traditional dot-product and consensus based spectra matching
approach do not fully utilize all the information contained in the spectra. The dot
product, for example, weights the contribution of each spectra peak only by its in-
tensity, without considering its consistency. Using a consensus spectrum assumes
that a single intensity value is sufficient to represent the range of intensities observed
in the experimental spectra. So a probabilistic model that can capture the spec-
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tra peak intensity consensus and variation pattern can potentially provide better
accuracy.
3.2 HMMatch: Peptide Identification by Spectral Matching of Tan-
dem Mass Spectra Using Hidden Markov Models
As described in section 3.1.2, the traditional peptide identification algorithms
tend to ignore the ion peak intensity information or only use partial intensity in-
formation. Even though some algorithms [BE01, SKSS03, Zha04, WYC06] have
tried to predict the probability of observing an ion or its intensity, when applied to
analyzing real life experimental spectra, the improvement made by these algorithms
seems limited.
Based on experimental observation, a hidden Markov model (HMM) [Rab89]
approach for spectral matching is designed and implemented. The approach uses
hidden Markov models to summarize the peak intensity consensus and variation
of example peptide fragmentation spectra. The unknown mass spectrum can be
identified by comparing with these peptide mass spectrum HMMs.
3.2.1 Related Work
3.2.1.1 HMM and Its Application to Peptide Identification
The HMM [Rab89, JR90, JR85] was initially introduced in late 1960s and early
1970s and was used for human speech recognition. It includes a class of statistical
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models used to capture statistical characteristics of time series and linear sequences.
HMM is basically a double embedded stochastic process with first order Markov
chain as underlying (hidden) stochastic process and state dependent probabilistic
function as the observable stochastic process. Because of the nice mathematical
properties of HMM, it was introduced into computational biology in late 1980s and
used to profile protein sequences [Edd98, KBM+94]. Later, HMM was also used to
model gene structure and predict protein structure by fold recognition.
Researchers have used HMM for peptide identification only recently. PepHMM
[WYC06] is one of these algorithms. It builds a HMM to capture the correlation
among matched and unmatched ions, which has not been proposed by any other
researcher. The proposed HMM is a general post-process model for any experimen-
tal spectrum to theoretical spectrum matching scheme, and it is used to re-access
experimental spectrum vs. theoretical spectrum comparison results. However, the
proposed model only distinguishes ions at the start, end and middle positions. As
shown by the preliminary results in the following results section, the intensity pat-
terns for ions change from peptide to peptide, so using one model can over-generalize
the hidden intensity information.
Other researchers have proposed a generative HMM of mass spectra for de novo
peptide sequencing called NovoHMM [FRR+05]. The model emulates the whole
mass spectra generation process in a probabilistic way. The results show NovoHMM
outperforms other de novo sequencing algorithms that use mass spectrum graphs
for generating candidate peptides. Researchers in signal processing area have also
used HMMs or similar models to correct mass spectra alignment along time axis, so
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as to extract the non-noise peaks using multiple alignment of continuous time series
[LNRE05, LE05].
3.2.2 Motivation
The motivation for using HMM for spectral matching starts with multiple
sequence alignment with HMM. Because of the similarities existing between two
problems, we found it natural to adapt the probability model and apply it to spectral
matching for tandem mass spectra.
3.2.2.1 HMMER for Multiple Sequence Alignment
Hidden Markov models have proved to be a powerful technique in statistical
machine learning, and have been used extensively in de novo gene finding and protein
family clustering and prediction [KBM+94, Edd98, FMSB+06]. In particular, the
use of hidden Markov models for protein families, as in Pfam [FMSB+06], suggests
that they may find application in spectral matching. Given a multiple alignment of
protein sequences that belong to the same protein family, the Pfam hidden Markov
model represents a statistical consensus for the amino acids observed at each po-
sition. Conserved positions tightly constrain protein family membership, while the
contribution of highly variable positions are down-weighted. The model also permits
the insertion or deletion of amino acids to align diverged sequences at positions of
significant conservation. The Pfam hidden Markov model, as a statistical signature
of a protein family, is more sensitive than sequence alignment with any single mem-
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ber of the family, and more specific than aligning against all protein family members.
Because of the similarity between statistical consensus of amino acids observed at
each position and statistical consensus of peak intensity at differetn m/z position,
it motivates us to use HMM to model mass spectra peak intensity consensus and
variation.
3.2.2.2 MS/MS Intensity Profile
Figure 3.2 summarizes the statistical properties of the low-mass region of a
set of spectra. These spectra are identified as peptide DLATVYVDVLK with high
confidence. The figure shows the distribution of normalized peak intensities before
log10 intensity transformation with box-plot. Regions denoted I0, I1, . . . represent
m/z value regions between singly charged b and y ions of peptide DLATVYVDVLK,
while the regions denoted b1, b2, . . . and y1, y2, . . . represent m/z values within 0.5 Da
of the corresponding b and y ions. Above each box-plot is the average frequency of
selected peaks, per spectrum, in each m/z region. While there is a lot of consistency
in the intensity of some ions, other ions’ intensity show considerable variation, and
some b and y ions are completely absent. The peak intensity consensus and variation
here is very similar to the consensus and variation of amino acids at each multiple
sequence alignment position. So the hidden Markov models are used to capture this
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Figure 3.2: Normalized intensity distribution (before log10 transformation) of low-
mass peaks in m/z regions between (I0, . . .) and near singly charged b (b1, . . .) and
y (y1, . . .) ions from training spectra for peptide DLATVYVDVLK. Average peak
frequency, per spectrum, in each m/z region is indicated above each normalized
intensity box-plot.
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3.2.2.3 HMM for Spectral Matching
The hidden Markov models are trained with a set of mass spectra that are con-
fidently assigned to a specific peptide X!Tandem [CB04]. Then the hidden Markov
models are used to evaluate additional mass spectra, and the results compared with
X!Tandem, Mascot and NIST’s MS Search software. This approach is different from
PepHMM [WYC06], which uses a single hidden Markov model to evaluate the qual-
ity of any peptide-spectrum match. The results show that the HMM MS/MS Match
(HMMatch) approach identifies many mass spectra left unidentified by Mascot and
X!Tandem. It is also more flexible and robust than MS Search. In the following
sections, the HMMatch design and the experimental evaluation of HMMatch for
peptide identification are described in details.
3.2.3 Training Data Selection
Both training and testing data (mass spectra) are processed and provided by
Professor Nathan Edwards. The following paragraphs are data selection method
described by Professor Nathan Edwards.
3.2.3.1 Mass Spectra Libraries
Public LC/MS/MS data sets derived from human samples are downloaded
from their respective data repositories. Sources include PeptideAtlas [DDK+06] and
Human Proteome Project (HUPO) Plasma Proteome Project (PPP) [OSA+05]. In
all, there are more than 2.3 million spectra stored locally for searching. These 722
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data files represent work from 33 different labs or projects. Tandem mass spectra are
re-searched using conservative search parameters: 1 missed cleavage, tryptic N and
C-terminals, methionine oxidation and cysteine alkylation modifications only, pre-
cursor mass tolerance 2 Da, and fragment mass tolerance 0.4 Da. The computation
is done with a computational grid of approximately 250 Linux CPUs managed by
the Condor scheduling infrastructure, and the X!Tandem search engine. The Mas-
cot search engine [PPCC99], tied to a single processor, is used for benchmarking,
comparison studies, specific identifications confirmation.
3.2.3.2 Data Selection
The results of re-searching public LC/MS/MS spectra are stored in a rela-
tional database. A small set of frequently observed peptides (in a particular charge
state) with many high-confidence peptide identifications are chosen. One HMMatch
model is constructed for each of these peptides. For each peptide model, the set of
MS/MS spectra extracted are with precursors within 2 Da of the peptide’s theoret-
ical monoisotopic m/z value.
These spectral sets are partitioned into five classes based on their X!Tandem
search results: High confidence identifications of the model peptide (denoted HC),
low confidence and non-significant identifications of the model peptide (LC), high
confidence identifications of a non-model peptide (HC-Other), low confidence and
non-significant identifications of a non-model peptide (LC-Other), and spectra with
no peptide identification with E-value less than 1 (Unknown). A 10−4 X!Tandem
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E-value threshold is used to delineate high-confidence identifications from other
peptide identifications. Approximately half of the model peptides’ high confidence
identifications are randomly selected for training (HC-Train), and the remaining
peptides are reserved for testing (HC-Test).
However, there is a problem when extracting evalues from search results. While
the E-values of high-scoring peptide identifications of model peptides are easy to
extract from Mascot and X!Tandem search results, E-values from low-scoring and
non-significant scores are more difficult to obtain, because the search engines output
only the top few best scoring peptides for each spectrum.
To obtain E-values with respect to the model peptides of weak identifica-
tions, a special decoy protein sequence database is constructed following [EHFG05a].
This sequence database consists of reversed protein sequences of the IPI-Human
[KDW+04] protein sequence database, plus (forward) protein sequences that contain
the model peptides. The size of this decoy database is consistent with IPI-Human,
and high-confidence identifications by X!Tandem and Mascot have similar E-values
as for a IPI-Human search.
The X!Tandem source code is modified to output all peptide identifications
with hyperscores within 80% of the best scoring peptide. Lastly, the precursor mass
tolerance parameter is increased to 4.5 (6.5) Da for spectra from charge 2 (3) peptide
spectra data sets. Using these techniques, it is able to obtain valid E-value estimates
for many spectra with respect to the model peptides, even when the identifications
are very weak or missing from our original re-search results. These E-value estimates




While the fragmentation spectra of peptides that subject to collision induced
dissociation are widely believed to be reproducible under a variety of experimental
and instrumental conditions, this reproducibility is difficult to observe without con-
siderable normalization of each spectrum. As described in [Ste94, SS94, YMG+98,
WYC06, CCFB06, FMW+06, LDE+06, SKN+06, LDE+07], a number of techniques
have been proposed to pre-process and normalize the spectra, whose peaks are rep-
resented by a list of positive real-valued (m/z,int) pairs, ordered by m/z. These
techniques include intensity normalization relative to the base peak or rank, m/z
binning and blurring, transformations such as the square root or logarithm of peak
intensity, and elimination of insignificant ions by intensity or ranking. However,
there seems to be little consensus, to date, on spectrum normalization techniques
for spectral matching, although the work of [WLM+05] provides some basis for
evaluating many possibilities.
For the proposed spectral matching framework, a number of normalization
procedures were tested and the procedure which produced good results was selected
to pre-process spectra data, although the selection is not based on comprehensive
examination of all the possibilities. This issue will be revisited in future work. The
following spectrum normalization techniques used by HMMatch are restricted to
those can be carried out without knowledge of the model peptide or global properties
of the training spectra, with the hope that these techniques might be useful in other
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settings.
Peak Intensity Normalization. The absolute value of peak intensities varies sig-
nificantly between mass spectra of the same peptide, due to peptide abundance
variation and different instrument technologies. The intensity of each peak in the
peak list is normalized by the 3rd most intense peak. The normalized intensity of
the 1st and 2nd peaks are reset to 100%. The 3rd most intense peak, rather than
the base peak, is used to avoid creating spurious variation due to a non-reproducible
base peak (often the precursor ion).
Peak Selection. To ensure that only the most informative peaks are used in HM-
Match training, only the top 10 peaks are kept with normalized intensity at least
1%. The selection of a small number of peaks ensures that the significant variation
in the number of small, insignificant, “grass” peaks in each spectrum is eliminated.
The resulting fixed length peak list ensures that HMMatch scores for different spec-
tra are consistent in magnitude. This aggressive peak selection does not compromise
HMMatch’s performance.
Intensity Transformation. Normalized intensities are transformed using the base
10 logarithm, which helps to moderate the larger variance observed in more intense




Normalized peak intensities are discretized with respect to 4 equal-sized bins
between the minimum and maximum normalized intensity values. For the spectrum
normalization described above, normalized intensities range from [0, 2], resulting in
normalized intensity bins [0.0, 0.5], (0.5, 1.0], (1.0, 1.5], and (1.5, 2.0]. We denote
these intensity bins I.
Each m/z value in the peak list is transformed from a positive real-valued
number to a symbol describing a region of the m/z axis. Let M = (m1, . . . , mk) be
an ordered sequence of theoretical m/z values of expected or commonly observed
ions, and ε be a suitable mass tolerance for matching observed peaks with the
elements of M . The values m0 = −ε and mk+1 = +∞ are added to M for notational
convenience. The m/z axis is then partitioned into 3k+1 regions: RLj = [mj −ε, mj ]
for j = 1, . . . , k, RHj = (mj , mj + ε] for j = 1, . . . , k, and Rj,j+1 = (mj + ε, mj+1 − ε)
for j = 0, . . . , k. Figure 3.3 shows these regions on the m/z axis. ε = 0.5 Da is used
throughout. The set of all such regions are denoted as R.
3.2.5 HMMatch Algorithm
The HMMatch hidden Markov model for peptide fragmentation spectra is
based on the protein family hidden Markov model used by the Pfam database, and
is shown in Figure 3.4.
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Figure 3.3: Discretization of m/z axis into regions. Valid m/z region emissions, for
each non-silent HMM hidden state, also shown.




The hidden Markov model represents each of a peptide’s commonly observed
or expected ions, with m/z value mj ∈ M , by a hidden state Sj. Initially states
only represent singly charged b and y ions for 2+ peptides. But later it is found
that by adding some doubly charged b and y ions and dropping rarely observed
ions, the predictive performance for 3+ peptides can be improved. These hidden
states, represented by squares in Figure 3.4, are ordered as in M . Insertion states
Ij,j+1 (diamonds in Figure 3.4) represent additional, unexpected, or unmodeled ions
between expected m/z values mj , mj+1 ∈ M . The absence of expected m/z values
is modeled by zero emission of intensity for ion states.
3.2.5.2 Emission Probabilities
Each non-silent state emits a discrete valued m/z value-intensity pair (m/z, int)
from R×I. The m/z value and intensity emission probabilities are modeled as inde-
pendent, so that PS(m/z, int) = PS(m/z)PS(int) for each non-silent state S. Each




j }. Similarly, each
insertion state Ij,j+1 between states Sj and Sj+1, for mj , mj+1 ∈ M emits peaks such
that m/z ∈ {RHj , Rj,j+1, R
L
j+1}. Figure 3.3 shows the valid m/z regions that may be
output by each non-silent state.
3.2.5.3 Transition Probabilities
Non-zero transition probabilities are shown as directed edges in Figure 3.4.
70
3.2.6 Statistical Significance of HMMatch Score
3.2.6.1 HMMatch Score
Once trained, the HMMatch hidden Markov model is used to assess the extent
that unknown spectra are consistent with the training spectra. Unknown spectra
are normalized and discretized, as above, and fed into the trained models. There are
several metrics that can be used to measure probability that the model generate the
given sequence: the Viterbi distance and Forward distance. The Viterbi algorithm
is used to compute the probability of the most likely path through the hidden
Markov model. The Forward algorithm is used to probability of a particular output
sequence. For HMMatch, both metrics are tested as HMMatch score, which equals
to − log10(p), where p is the probability of the Viterbi path or the probability of
Forward probability. The experimental results will show that both metrics have
similar behavior for the selected data sets.
However, because the HMMs are different for different peptide mass spectra
patterns, HMMatch score cannot be used for the comparison across different mod-
els. Random spectra are needed to normalize HMMatch score and give statistical
significance for the spectra identification results.
3.2.6.2 Random Spectra
Generating random spectra for statistical significance models must be done
with care. Naively generated random spectra are so unlike peptide MS/MS spectra
that even poor HMMatch scores appear statistically significant. To provide good
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statistical significance estimation of the results, it is required that the random spec-
tra look enough like true peptide fragmentation spectra so that poor HMMatch
scores are not statistically significant, while good HMMatch scores are still unlikely
to be observed.
The intensity and m/z value properties of discretized, normalized training
spectra are extracted independently. Each peak list contains 10 peaks, 3 of which
have normalized intensity 100%, by construction. The discrete intensities of the
remaining peaks in each training spectrum are tabulated to construct an empirical
probability density for peak intensity.
The probability density of the discretized training spectra m/z values is deter-
mined from the m/z values of the top N most intense peaks in each spectrum, for
some N ≥ 10. As with the intensities, the m/z regions are tabulated to construct an
empirical probability density. For small N , the probability density strongly favors
m/z regions corresponding to very abundant ions, while for large N , the probability
density weights m/z regions according to their size. If the probability density favors
abundant ions from the training set too heavily, even for large N , pseudo-counts
are added to the m/z regions. As the pseudo-counts increase, the m/z regions are
sampled according to their size and all information about the m/z values of the
abundant ions in the training spectra is lost.
Once the empirical distribution of m/z values and intensities from the training
spectra are established, random spectra are generated by choosing 10 peaks accord-
ing to the discrete intensity and m/z region probability densities. Three peaks are
assigned intensity 100%, with the rest drawing their intensity independently from
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the empirical intensity distribution. Each of the peaks draws their m/z value from
the empirical m/z value distribution independently of each other, and their intensity
values.
The parameters of this random spectrum generation technique serve to favor,
or discount, the selection of abundant training spectra m/z values. Initially set the
pseudo-counts are set to zero and the parameter N is adjusted until the distribution
of the HMMatch scores of random spectra matches the distribution of the HMMatch
scores of HC-Other spectra. Pseudo-counts are used if no value of N is sufficient.
3.2.6.3 Score Distribution and p-value Estimation
Experiments results show that the normal distribution, with appropriately
chosen mean and variance, is a good fit to the empirical shape of the HMMatch
scores from random spectra. The mean and variance of HMMatch scores of 1000
random spectra are easily computed, and are used to transform HMMatch scores to
normal distribution z-scores to estimate p-values.
3.2.7 Implementation
HMMatch was written in C++. It is implemented on top of LAMP HMM
v. 0.9. LAMP HMM is a general implemtation of HMM algorithm. It is imple-
mented by Daniel DeMenthon and Marc Vuilleumier. The code was downloaded
from http://www.cfar.umd.edu/~daniel/Site_2/Code.html. It allows observa-
tions to be vectors and the observation probabilities to be modeled by histograms
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or Gaussians. It also provides both Baum-Welch method and segmental k-means
method for training. The other implementation properties not related to HMMatch
are listed on the software website.
The mass spectra data used for training and testing HMMatch are processed
and provided by Professor Nathan Edwards. The data selection approach is de-
scribed in section 3.2.3.
3.2.8 Experimental Results
3.2.8.1 Experimental Data
For our experiements, we selected eight peptide/charge state combinations
of mass spectra from the relational database of identified spectra. The peptides,
their m/z value, and the number of spectra in each category is shown in Table 3.1.
Peptides were selected from those with the most high-confidence identifications in
the relational database.
3.2.8.2 Training
After training the HMMatch models using the Baum-Welch algorithm the
performance of each model on each spectrum class is evaluated. Given the relatively
small number of training examples for each peptide, special attention must be paid
to the possibility of over-fitting the model. This issue is carefully considered in
the hidden Markov model design, particularly in the spectrum discretization and
emission probability independence assumption, and in the initialization of intensity
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Peptide
m/z z HC-Train HC-Test LC HC-Other LC-Other Unknown
DFLAGGVAAAISK
610.34 2 36 23 59 48 879 22481
DFLAGGIAAAISK
617.35 2 33 36 14 113 804 5001
DLATVYVDVLK
618.35 2 36 40 61 159 772 4615
AVMDDFAAFVEK
671.82 2 110 82 143 205 820 5543
LNDLEDALQQAK
679.35 2 28 28 45 169 741 7591
AVM*DDFAAFVEK
679.82 2 56 50 52 116 723 7585
SHCIAEVENDEMPADLPSLAADFVESK
992.12 3 27 25 140 162 1317 6208
SHCIAEVENDEM*PADLPSLAADFVESK
997.45 3 40 40 125 128 1192 6074
Table 3.1: Model peptides and spectral data set sizes. Cysteines alkylated with
iodoacetamide. * indicates oxidized methionine.
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emission probability distributions. Plotting the distribution of HMMatch scores
(Figure 3.5) for the HC-Train and HC-Test spectra shows that there is no evidence of
over-fitting. In each case, the distribution of training scores match the distribution
of testing scores. Furthermore, it is observed that there is excellent separation
between the HMMatch scores of the spectra with high-confidence identifications to
the model peptide (HC-Test) compared with that of other peptides (HC-Other).
This implies that HMMatch has similar specificity as X!Tandem with respect to
spectra with high-confidence identifications. Because the distribution of viterbi
scores and forward scores are very similar, only results for forward scores are shown
here. This is mainly because of the proposed data pre-processing and model building
algorithm, which give very sparse transition matrix with most non-zero elements lie
along the diagonal.
The time to train each HMMatch model varies depending on the number of
states, the number of training spectra, and the number of Baum-Welch iterations
required for convergence. Table 3.2 shows these statistics for each model. Most of
the HMMatch models were trained in less than 10 seconds, with the longest training
time less than one minute.
Computation of the HMMatch score (for both viterbi score and forward score)
is also quite fast. Table 3.3 shows the time to compute HMMatch scores for each
peptide’s spectra. Viterbi distance evaluation time depends primarily on the num-
ber of states in the hidden Markov model. While more time-consuming than the
sequence and dot-product based search engines, the time to compute HMMatch
scores is not prohibitive, even for very large spectral data sets, despite the use of a
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Figure 3.5: HMMatch forward scores for spectra with high-confidence identifica-
tions (X!Tandem E-value < 10−4). High-Confidence Train (HC-Train) ⋆; High-
Confidence Test (HC-Test) ◦; High-Confidence Other (HC-Other) 3.
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Peptide
Time (s) Iterations States Spectra
DFLAGGVAAAISK
6 2 81 36
DFLAGGIAAAISK
5 2 81 33
DLATVYVDVLK
4 2 69 36
AVMDDFAAFVEK
16 2 75 110
LNDLEDALQQAK
3 2 75 28
AVM*DDFAAFVEK
8 2 75 56
SHCIAEVENDEMPADLPSLAADFVESK
16 2 120 27
SHCIAEVENDEM*PADLPSLAADFVESK
44 2 141 40
Table 3.2: Time (in seconds) for HMMatch training.
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generic hidden Markov model codebase that does not take advantage of our model’s
sparsity.
3.2.8.3 Basic Performance
The sensitivity of HMMatch is evaluated by plotting the distribution of HM-
Match score p-values for spectra with weak or no identifications. Figure 3.6 give the
p-values for Forward scores. Because Viterbi scores and Forward scores have very
similar distribution, their p-values have similar distribution too, here only p-values
for Forward scores are shown. Performance wise, a large proportion of the spec-
tra with weak identifications to the model peptide (LC) have very small p-values,
demonstrating higher confidence than X!Tandem for these peptides. A few weak
identifications to other peptides (LC-Other) have quite significant HMMatch scores
which suggests the weak X!Tandem identifications are incorrect. Lastly, a consid-
erable fraction of the spectra with no identification with E-value ≤ 1 (Unknown)
have significant HMMatch scores. A number of thes cases are manually examined
and discussed in the following paragraphs. In each case it is found that spectra with
significant HMMatch scores are an excellent match to high confidence spectra from
the model peptide.
The performance of HMMatch is tested as the number of training spectra
is reduced. HMMatch models for the peptides LNDLEDALQQAK and DFLAG-
GIAAAISK are constructed using training sets consisting of 5, 10, 20, and 40 ran-
domly selected HC spectra. For peptide LNDLEDALQQAK, the distribution of
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Peptide

















Table 3.3: Time (in seconds) to compute HMMatch scores.
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Figure 3.6: HMMatch forward score based p-values of low-confidence and unknown
spectra (X!Tandem E-value > 10−4). Low-Confidence (LC) ⋆; Low-Confidence
Other (LC-Other) ◦; Unknown 3.
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HMMatch scores for HC-Test and HC-Other overlap a little for 5 training spec-
tra, but are completely separated for 10, 20, and 40 training spectra. For peptide
DFLAGGIAAAISK, the HC-Test and HC-Other scores are well separated for all
training set sizes from 5 to 40. As with all machine-learning techniques, HMMatch
training is more effective as the number of training examples increases, however,
these experiments demonstrate that good performance is possible even with a rela-
tively small number of training spectra per peptide.
3.2.8.4 Comparative Performance
Because of the absence of a sufficiently rich data set with known correct peptide
identifications, it is not easy to establish performance in terms of sensitivity and
specificity. To provide reasonable performance results, HMMatch is compared with
sequence database search engines X!Tandem and Mascot, and spectral matching
search engine MS Search from NIST with consensus spectra from the NIST library
of peptide fragmentation spectra. Precision-recall statistics are used to compare the
tools’ peptide identification scores. Some of the cases are manually examined to
show that HMMatch is able to confidently identify some spectra, while the other
tools cannot.
Performance Comparison. Each tool orders the spectra in each data set according
to some spectrum-peptide match score. For X!Tandem and Mascot, this is the E-
value, for NIST’s MS Search this is the match factor, and for HMMatch this is the
HMMatch score described above. Given a reference labeling as positive or negative
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with respect to the model peptide, it can be evaluated that, with respect to any
spectrum-peptide match score threshold, the extent to which the partition of the
spectra using this threshold is consistent with the reference labels. The spectrum-
peptide match score and threshold and the reference labels partition the spectra
into true-positive (TP ), false-positive (FP ), false-negative (FN), and true-negative
(TN) sets. Precision, then, is defined as |TP |/(|TP |+ |FP |), while recall is defined
as |TP |/(|TP | + |FN |). Perfect correspondence with the reference labels, for a
particular match score and threshold, results in 100% precision and 100% recall. The
precision-recall curve, which plots the precision-recall statistics for all thresholds,
captures the extent to which the ranking of spectra by some match score is consistent
with the reference partition of the spectra into positive and negative examples.
Perfect correspondence with the reference labels results in a square precision-recall
curve.
Each tool is compared to the others by using each tool and some spectrum-
peptide score threshold, in turn, to construct synthetic reference labels. As such,
these precision-recall statistics and curves do not represent true measures of sensitiv-
ity and specificity, instead they capture the extent that each tool’s spectrum-peptide
match score ranks the spectra in an order that is consistent with the synthetic ref-
erence. Figure 3.7 show a complete set of precision-recall curves for the synthetic
reference based on X!Tandem E-value and significance threshold 0.01. To summa-
rize the comparative behavior more comprehensively, table 3.4 show the % recall
at 99% precision for each tool averaged across the eight data sets, with respect to
synthetic reference labels derived from each tool’s spectrum-peptide match score.
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Figure 3.7: Precision-recall curves for Mascot ( ), MS Search ( ), and HMMatch
( ) for synthetic reference labels defined by X!Tandem E-value threshold 0.01.
Training spectra and spectra with no X!Tandem E-value for the model peptide are
excluded.
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Reference Threshold Pos./Neg. X!Tandem Mascot MS Search HMM
X!Tandem 0.1 93 / 12 - 59% 54% 53%
(E-value) 0.05 90 / 15 - 56% 54% 54%
0.01 79 / 26 - 48% 37% 43%
0.001 61 / 44 - 38% 14% 32%
Mascot 0.1 38 / 67 38% - 33% 40%
(E-value) 0.05 34 / 71 42% - 35% 34%
0.01 26 / 79 45% - 26% 33%
MS Search 0.8 52 / 63 46% 61% - 60%
(Match Factor) 0.9 62 / 53 36% 55% - 49%
0.95 72 / 43 32% 42% - 46%
Table 3.4: Average % recall at 99% precision for 8 model-peptide spectrum data
sets with respect to various synthetic reference labels. Training spectra and spectra
with no reference score excluded.
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The precision-recall curves and statistics show only a moderately good corre-
spondence between the ranking imposed by any pair of tools. Table 3.4 shows that
for high precision identification, the HMMatch score is more like X!Tandem and
Mascot than MS Search, particularly for the smaller E-value synthetic label thresh-
olds. For spectral matching synthetic labels from MS Search, HMMatch shows a
similar degree of correspondence as Mascot, with X!Tandem showing quite a bit less.
The precision-recall curves in Figure 3.7 show there is no tool that is uniformly more
consistent with X!Tandem than the others. For four of the eight data sets, the HM-
Match score recalls the most spectra at 100% agreement with X!Tandem, Mascot
and MS Search recall the most for two each of the remaining data sets. Peptide SH-
CIAEVENDEMPADLPSLAADFVESK shows considerable disagreement between
the search engine tools and the spectral matching based tools, with strong agree-
ment between the spectral matching based tools. On the other hand, peptide
AVM∗DDFAAFVEK shows considerable difference between the spectra matching
based tools, as compared to X!Tandem. On the strength of the precision-recall
curves and statistics, it is not hard to conclude that HMMatch shows a similar
level of concordance with the other tools as they do to each other. It also shows
that HMMatch does not seem to be overtrained or biased towards the X!Tandem
identifications, despite the use of these identifications in HMMatch training.
Case Study. Our data sets contain many spectra with highly significant HMMatch
scores but with poor scores from X!Tandem and Mascot. HMMatch confidently
identifies, with HMMatch score p-value < 10−5, 3537 spectra with both Mascot and
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X!Tandem E-values greater than 0.05. By way of comparison, NIST’s MS Search
confidently identifies, with match factor threshold 0.9, only 673 spectra with both
Mascot and X!Tandem E-values greater than 0.05. A number of these spectra are
manually examined to determine whether or not HMMatch was likely correct and
to try to explain the poor scores from other tools.
A considerable proportion (3̃50) of the spectra were correctly identified by
HMMatch and misidentified by the search engines due to peptide candidate selection
issues. It was observed that there were a large number of misidentified spectra with
precursor molecular weight outside of the allowed search engine precursor tolerance
of 2 Da. The spectral matching techniques also use a precursor tolerance of 2
Da, but it is applied to the m/z value of the precursor. When the search engine
parameter is increased to 4 Da (6 Da) for charge 2 (charge 3) peptides, these spectra
are usually confidently identified as the corresponding model-peptide by X!Tandem
and Mascot. So, while these spectra are confidently identified by HMMatch, they
are not a good demonstration of the strength of HMMatch scores as compared
to the peptide sequence based scoring. However, it does suggest that the usual
2 Da precursor tolerance used for sequence searching is perhaps too aggressive.
Nevertheless, increasing the precursor tolerance increases Mascot and X!Tandem
E-values by a similar factor, further reducing their sensitivity.
Another class of spectra correctly assigned by HMMatch, but with poor X!Tandem
and Mascot scores, are noisy spectra with many extraneous peaks, as in the frag-
mentation spectrum of peptide DLATVYVDVLK in Figure 3.8(a). This spectrum,
confidently identified by HMMatch with p-value 7.341 × 10−12 has Mascot E-value
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1.07 and X!Tandem E-value 0.0013. While X!Tandem’s E-value is less than typical
significance thresholds, the E-value does not indicate the same degree of confidence
as HMMatch. The sequence database search engines have trouble with these spectra
as the extra peaks tend to match fragment ions whether or not the correct peptide
is being evaluated. The MS Search spectral matching search engine computes a
match factor of 0.844 for this spectrum-peptide combination, well below match fac-
tors for other high-confidence peptide identifications. The dot-product based match
factor is affected by noisy spectra, as documented by [MSS05]. It is believed that
the aggressive peak selection strategy used for spectrum normalization makes the
HMMatch robust with respect to the presence of extraneous noise peaks, without
compromising identification performance.
The fragmentation spectrum, also of peptide DLATVYVDVLK, in Figure 3.8(b)
represents another interesting failed identification by Mascot and X!Tandem that is
correctly identified by HMMatch. The HMMatch score has significance 1.738×10−12,
while MS Search computes a match factor of 0.994. Mascot, on the other hand,
computes an E-value of 5.7 and X!Tandem an E-value of 0.16, neither of which
is statistically significant. Close examination of the search engine results revealed
that the spectrum received poor scores due to the fragment ion mass tolerance pa-
rameter. The X!Tandem and Mascot searches were conducted using a fragment ion
match tolerance of 0.4 Da, a relatively conservative fragment tolerance appropriate
for the ion trap spectra that makes up the majority of publicly available MS/MS
spectra. However, for the spectrum of Figure 3.8(b), b4 and y3 ions, amongst others,
were observed more than 0.4 Da from their theoretical value, which was sufficient
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to drive down the search engine scores. Increasing the fragment tolerance increases
Mascot and X!Tandem E-values, further reducing their sensitivity. HMMatch uses
a fragment tolerance of 0.5 Da, and matched b4, but didn’t even use the peak that
matched y3 as it was outside of the 10 most intense peaks. The MS Search match
factor was computed using the default bin-size of 0.8 Da, so the measurement error
apparent in these fragment ions did not affect its score. We believe that the use of
peak intensity by HMMatch makes it possible to use a larger fragment ion tolerance
and more aggressive peak selection, without sacrificing identification performance.
a)
b)
Figure 3.8: Case study fragmentation spectra of peptide DLATVYVDVLK. (a)
Mascot E-value: 1.07, X!Tandem E-value: 0.0013, MS Search match factor: 0.844,
HMMatch p-value: 7.341 × 10−12; (b) Mascot E-value: 5.7, X!Tandem E-value:
0.16, MS Search match factor: 0.994, HMMatch p-value: 1.738 × 10−12.
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3.2.9 Model Extrapolation
Traditional spectral matching, which uses dot-product based similarity scores,
essentially treats the reference spectra as bitmapped images with no semantic con-
tent. The use of artificial consensus spectra, which implicitly encodes semantics
by retaining only frequently observed or expected peaks and permits asymmetric
variants of the dot-product based similarity measures, is the approach adopted by
NIST for its GC/MS [SS94] and peptide fragmentation spectral libraries, as well as
the MS Search spectral matching search engine.
The construction of a probability model, such as HMMatch, to abstract and
semantically summarize the behavior of a set of peptide fragmentation spectra makes
it possible to extrapolate the model to spectra from other, related, peptides. Two
peptides that differ by a single amino acid or by the addition or removal of a post-
translational modification will, in many cases, have similar normalized intensities,
once an appropriate offset is applied to some of the ions. For example, the peptides
DFLAGGVAAAISK and DFLAGGIAAAISK differ by a Val to Ile substitution, a
mass shift of +14.02 Da, which affects the m/z value of all the fragment ions that
contain the changed residue, including b7, . . . , b12 and y7, . . . , y12, and of course the
precursor. Other than this mass shift, however, the peptide fragmentation spectra
of these peptides are very similar. Figure 3.9 shows the spectral box-plot of HC-
Train spectra, defined as for Figure 3.2, for each of these peptides. This figure,
which plots the distribution of intensities in each of the discrete m/z regions of R,
abstracts away the shift introduced by the amino acid substitution and makes the
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similarity apparent.
Given the semantic abstraction of our trained HMMatch model, it is straight-
forward to compute the HMMatch scores of spectra of one peptide using the HM-
Match model of the other. Our set of spectra includes three such pairs: DFLAG-
GVAAAISK and DFLAGGIAAAISK, AVMDDFAAFVEK and AVM∗DDFAAFVEK;
and SHCIAEVENDEMPADLPSLAADFVESK and SHCIAEVENDEM∗PADLPSLAADFVESK.
The last two pairs differ by an oxidized methionine (+15.99), indicated by ∗, while
the first pair has an amino acid substitution, as already described. For each pep-
tide, we compute the p-value of the HMMatch score of HC-Test spectra using both
the original HMMatch model and the extrapolated model of its twin. Figure 3.10
plots the original Viterbi score based p-value vs the extrapolated Viterbi score based
p-value for each of the six paired peptides. The line y = x is added to provide a
visual aid for estimating the number of HC-Test spectra with increased or decreased
significance.
It is observed that while the p-values are somewhat scattered, most spectra
with statistically significant HMMatch scores computed using the correct model are
still statistically significant with respect to the extrapolated twin peptide’s HM-
Match model. In fact, a good number of the HC-Test spectra are more significant
(lie above the y = x line) when scored using the twin’s model. The success of this
model extrapolation suggests that HMMatch models may be created and used to
identify peptides from a specific isoform or modification, even when their spectra
have not previously been identified by other tools. Similarly, it may be possible








b3 b4 b5 b6 b7 b8 b9 b10 b11y2 y3 y4 y5 y6 y7 y8 y9 y10 y11
DFLAGGIAAAISK
Figure 3.9: Normalized intensity boxplots for peaks in each m/z value region from
HC-Train spectra of DFLAGGVAAAISK and DFLAGGIAAAISK.
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Figure 3.10: Comparison of p-values of HC-Test spectra scored with the peptide’s
HMMatch model and the extrapolated HMMatch model of its related “twin” pep-
tide.
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peptides, useful when there are too few high-confidence training spectra for each
individual peptide.
While many related peptides have similar (up to mass shift) spectra, this is
clearly not true for all amino acid substitutions (in particular, the insertion of a basic
residue) and post-translational modifications. While it is not necessarily be able to
predict which related peptides will have similar spectra, the statistical significance
computation ensures that extrapolated model assignments are not accepted when
they are unlikely to be correct.
A larger problem for HMMatch is the linear, ordered, structure of the expected
ion hidden states. If the masses of expected or common fragments ions after the
mass shift is applied are no longer correctly ordered, then it is unclear how the
hidden Markov model’s transition probabilities should be adjusted to compensate.
For each of the peptide pairs above, the mass shift is small enough that this is not
an issue.
3.2.10 Conclusion
HMMatch is a novel approach for spectral matching based peptide identifi-
cation. It uses a hidden Markov model to summarize the statistical variation and
consensus in a peptide’s fragmentation spectra and applys this model to the identi-
fication of unassigned spectra.
The experiments results indicate that HMMatch has good specificity and su-
perior sensitivity, compared to sequence database search engines such as X!Tandem.
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The HMMatch design achieves good results from relatively few training spectra, is
fast to train, and can evaluate many spectra per second. A statistical significance
model permits HMMatch scores to be compared with each other (and with other
peptide identification tools) on a unified scale. HMMatch shows a similar degree
of concordance with X!Tandem, Mascot, and NIST’s MS Search, as they do with
each other. This suggests that each tool can assign peptides to spectra that the
others miss. Finally, it is shown that it is possible to extrapolate HMMatch models
beyond a single peptide’s training spectra to the spectra of related peptides, thus
expand the application of spectral matching techniques beyond the set of peptides
previously observed.
As the popularity of protein characterization by tandem mass spectrometry
grows and the public repositories of peptide fragmentation spectra to increase in
size, covering a larger proportion of more organisms’ proteomes with more examples
of mass spectra from a variety of instruments, the hidden Markov model approach
to spectral matching will become increasingly useful in the analysis of peptide frag-
mentation spectra.
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3.3 PepArML: An Unsupervised, Model-Free, Combining Peptide
Identification Arbiter for Tandem Mass Spectra Via Machine
Learning
3.3.1 Related Work
As mass spectrometry techniques advance, many database search algorithms
and tools are being developed to provide more precise peptide identification results.
However, current algorithms for peptide identification have much room for improve-
ment. Researchers have proposed many different approaches for enhancing existing
proteomics tools. A variety of techniques have been applied to protein sequence
database search engine outputs in order to improve the reliability of peptide identi-
fication. In general, these techniques treat the search engines as “black boxes”, and
try to do a better job at distinguishing correct from incorrect peptide identifications
by directly processing search engines’ peptide identification results. These black-
box tools employ one or more of the following techniques: combining or merging of
search engine results, supervised and semi-supervised machine learning scoring and
prediction, statistical significance re-estimation.
3.3.1.1 Combining Multiple Search Engines
One of the important techniques that researchers proposed is to combine re-
sults from multiple peptide identification tools. These result combiners [RMAM+04,
STN08, HKB+07] rely on peptide identification results from multiple search engines
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to improve sensitivity and specificity, with the assumption that search engine agree-
ment increases the likelihood that the identification is correct.
Higgs et al. [HKB+07] uses blackbox techniques to combine peptide identifi-
cation results from multiple search engines (SEQUEST and X!Tandem). They use
reverse database search results as null models to re-estimate the statistical signifi-
cance of the peptide identifications.
Scaffold [STN08] is a commercial tool from Proteome Software that uses sta-
tistical algorithms to combine results from multiple search engines to calculate the
probability that proteins are actually in a biological sample. Statistical significance
re-estimation techniques are used to normalize and compare scores from multiple
search engines. Scaffold also provides an interface for displaying proteins identified
in a tandem mass spectrometry experiment.
3.3.1.2 Applying Machine Learning To Improve Scoring
Supervised machine learning techniques [KNKA02, UZQA06, HKB+07, ALPN03,
BBIK04] have been applied to existing and novel features derived from search en-
gines’ results. These derived score functions demonstrate better sensitivity and
specificity for specific data sets.
PeptideProphet [KNKA02] was designed to re-estimate the statistical signifi-
cance of SEQUEST’s peptide identification results. It uses expectation maximiza-
tion algorithm to learn to distinguish correct from incorrect database search results.
The author claims this approach also applies to other database search based peptide
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identification algorithm. PeptideProphet first uses a supervised training phase to es-
tablish the optimal linear weighting of the various SEQUEST peptide identification
properties and scores. Then it uses an unsupervised empirical fit of a bimodal mix-
ture model to the discriminant scores to establish the likelihood of correct peptide
identifications.
Ulintz et al. [UZQA06] try to classify the database search engines’ peptide
identification results by applying machine learning algorithms (Boosting and Ran-
dom Forest) on peptide identification results. They not only directly use the peptide
identification results given by the search engines, but also design new metrics to be
incorporated in the feature vector correspondent to each peptide identification re-
sult. The machine learning framework show significant improvement over original
search engines peptide identification results.
Anderson et al. [ALPN03] use machine learning algorithms, support vector
machine, and 13 carefully constructed metrics as features to distinguish correct from
incorrect peptide identifications output by SEQUEST. The results show machine
learning based approach improves sensitivity compared with the original SEQUEST
scores.
Baczek et al. [BBIK04] use artificial neural network (ANN) to re-analyze SE-
QUEST’s peptide identification results based on a series of calculated peptide identi-
fication metrics. The results show ANN can be used to automate peptide identifica-
tion results’ classification even though they applied strict restriction when selecting
the training and testing data.
Supervised machine learning techniques are also often combined with statisti-
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cal significance re-estimation techniques [KNKA02, HKB+07] to normalize the class
prediction probabilities.
3.3.1.3 Re-estimating Statistical Significance
There have been several techniques to estimate statistical significance of pep-
tide identification results. The unsupervised E-M algorithm phase of Peptide-
Prophet [KNKA02] uses empirical properties of the underlying search engine results
as a null-model to re-estimate the statistical significance or likelihood associated
with peptide identification results. Its unsupervised significance re-estimation algo-
rithm helps to make its probabilities quite robust, as long as the underlying linear
discriminant model generalizes well enough to distinguish correct and incorrect iden-
tifications.
Other tools such as Qscore [MYL02] use a theoretical model to re-estimate the
significance of peptide identification results. Qscore was one of the first algorithms
that tries to use blackbox techniques to re-classify database search engines’ peptide
identification results. The scoring system incorporated more metrics about peptide
matching quality other than original SEQUEST scores. The results show that the
re-estimated statistical significance score performs better for distinguishing correct
from incorrect peptide identifications.
A current popular strategy is to use a decoy database [EHFG05a, EHFG05b,
HKB+07] to re-estimate the statistical significance of search engine outputs. A decoy
protein sequence database is constructed using either reversed or shuffled protein
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sequences. Peptide sequences in the decoy databases are assumed to be non-existent
and will not match experimental mass spectra. Any peptide identifications from
sequences in the decoy databases can thus be assumed to be false. By measuring
the proportion of peptide identifications that are generated by the decoy database
at different score thresholds, the statistical significance of search engine scores may
be re-estimated.
Elias et al. [EHFG05a, EHFG05b] mentioned several approaches for estimating
false discovery rates in their papers. They provided detailed descriptions of different
approaches in the supplementary section of their papers. We use the method they
propose for calculating false discovery rates since they seem to be the research group
performing the most extensive studies on estimating false discovery rates.
3.3.2 Motivation
A major concern with supervised machine learning techniques is the question of
how to generalize the trained machine learning model to peptide identification results
from a different instrument or search engine. One solution is to use unsupervised
or semi-supervised training. This approach makes it possible for the training to be
applied on the fly to each new data set. The procedure can also be adapted to
the particular features of a given set of results as needed. Semi-supervised machine
learning has recently emerged [CN08, KCW+07] as a solution to the concerns about
the generality of supervised machine learning. This type of approach uses decoy
database hits as known false peptide identifications to guide the machine learning
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approach.
A second concern with the black-box output re-analysis techniques is that
they require the correct (and incorrect) peptide identifications follow some under-
lying mathematical model. Sometimes these model assumptions are explicit, espe-
cially when using LDA [KNKA02] and SVM [ALPN03] machine learning techniques.
While in other cases they are implicit, such as the assumption that incorrect peptide
identifications from different search engines are uncorrelated [RMAM+04, STN08,
HKB+07].
To ally these concerns, we propose and test PepArML, a model-free, result
combining, unsupervised machine-learning approach to improving the sensitivity of
peptide identifications. Because PepArML does not rely on a fixed model or require
pre-labeled training data, it can be adapted to individual data sets on the fly auto-
matically. Experimental results indicate it outperforms each of the described basic
techniques.
3.3.3 Performance Metric Definitions
Throughout this section, a number of standard performance metrics are used
to evaluate the peptide identification results from different algorithms and database
search engines. For brevity we refer to an individual mass spectrum to peptide
identification generated by a search engine as a peptide ID.
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3.3.3.1 Definitions
We define the ground truth as the correctness of each peptide ID. We can
determine ground truth only for a synthetic protein mixture where we know the
identity of each protein in the mix. A peptide ID is considered to be true if the
spectrum is assigned a peptide from one of the proteins known to be in the synthetic
protein mix. A peptide ID is considered to be false if the spectrum is assigned to a
peptide from any other protein in the database. For the selected peptide IDs, the
number of true positives (TP), false positives (FP), false negatives (FN), and true
negatives (TN) is counted with respect to the known ground truth.
Sensitivity, defined as TP/(TP+FN), is also known as true positive rate (TPR).
It measures the percentage of true cases that are correctly classified (identified).
Specificity is defined as TN/(FP+TN). It measures the percentage of false cases that
are correctly classified. The false positive rate (FPR) is defined as (1−specificity).
False discovery rate (FDR), defined as FP/(FP+TP), measures the percentage
of false positives among classified true cases. Alternatively, FDR can be viewed as
the expected proportion of false positives among the declared significant results.
Notice that FDR and FPR are two different values.
FDR is a method commonly used in multiple hypothesis testing in order to
correct statistical significance for multiple comparisons. It is needed since E-values
reported for each peptide ID only reflect the statistical significance of individual
predictions. When combining results for thousands of peptide IDs, FDR provides
a more accurate prediction of the statistical significance of the entire collection of
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predictions.
3.3.3.2 Calculating FDR and Estimated FDR (eFDR)
To compute FDR requires knowledge of ground truth for each data set, which
is not possible for experiments with unknown proteins. Fortunately, decoy databases
(described in Section 3.3.1.3) may be used to compute an estimated false discovery
rate (estimated FDR, or eFDR) for each peptide identification algorithm [EHFG05a],
by considering all peptide IDs from sequences in the decoy database to be false pos-
itives. When calculating eFDR using decoy protein sequence databases, the original
(true) protein sequences are referred to as the forward database, and searching the
original database is referred to as a forward database search.
We use #F to represent the number of peptide IDs from the forward database
search. #Ft then represents the number of true positives in forward database search,
and #Ff represents the number of false positives in forward database search. Since
#F = #Ft + #Ff, FDR can calculated as:
FDR = #Ff/#F = #Ff/(#Ft + #Ff)
Similarly, we use #R to represent the number of peptide IDs from the decoy
database. It turns out that #R can also be used to estimate the number of false
positives in forward database search (#Ff), based on assumption that the random
matches appear with equal frequency in searches against both the forward and decoy
database sequences.




FDR’ = 2#R’/(#F’ + #R’)
if the forward and decoy database (of equal size) are concatenated. #F’ and #R’
are number of peptides IDs from forward and decoy database when the forward
and decoy databases are concatenated, so their values can be smaller than #F
and #R. In practice, no method for calculating estimated FDR has been proven
optimal. Theoretically, concatenated database and using #R/#F provides better
FDR estimations. But in real experiments, especially when results with FDR ≤
0.2 are most important, using either concatenated or separate forward & decoy
databases (and either #R/#F or 2#R/(#F+#R)) seem to provide similar results.
However, since scores (E-values) from different search engines need to be calibrated,
in the thesis we use the method suggested by Elias et al. [EHFG05a] to calculate
estimated FDR as 2#R’/(#F’ + #R’).
3.3.3.3 Experimental Metrics
To the experiment evaluation section, we use a number of different metrics to
evaluate the performance of each peptide identification algorithm:
Receiver Operating Characteristic (ROC) curves. ROC are plots of the sensitivity
vs. (1–specificity), which equals to the true positive rate vs. the false positive rate,
for all possible threshold values. ROC curves provide a global view of the sensitiv-
ity/specificity tradeoff of a particular predictor,and evaluate the predictor’s ability
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to separate true from false peptide IDs.
Area under ROC (AUROC). AUROC is a single-value summary of a ROC curve,
where higher values are desirable. A predictor that separates true and false peptide
IDs perfectly will have a square ROC curve and AUROC of 1.
Sensitivity for given FDR. The sensitivity of each predictor is evaluated at score
thresholds for different values of FDR or estimated FDR. These graphs are similar
to ROC curves, but somewhat more practical since eFDR may be computed without
knowing actual ground truth (which is needed for computing ROC and true FDR).
This metric can be used to evaluate predictor performance on a data set derived
from real biological samples, even though estimated FDR may not approximate true
FDR very well.
3.3.4 Heuristics For Combining Search Engine Results
To test whether machine learning is necessary to achieve good performance,
we designed several simple heuristic algorithms for combining search engine results.
The assumption of the algorithms are based on a widely used notion that when
different search engines give the same peptide identification, the identification is
more likely to be correct [RMAM+04].
A heuristic combiner must choose two outputs. First, the combiner must
decide which peptide to assign to each spectrum, choosing among all the peptide IDs
for that spectrum produced by the individual search engines. We tested combiners
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that selected peptide assignments based on either consensus (voting) or purely based
on peptide ID scores. Second, the combiner must assign a score to the peptide ID
selected. We tested combiners that used either E-values or eFDR scores, selected
in a variety of ways.
Except for MIN-Evalue and MIN-eFDR, heuristic combiners are majority vot-
ing based, where peptide IDs for a spectrum are chosen based on the largest number
of agreeing search engines. For instance, for a given spectrum if two search engines
select peptide x and one search engine selects peptide y, a voting heuristic always
assigns peptide x to the spectrum, regardless of the scores assigned by each search
engine (even if the peptide ID for y has a much higher confidence score than the
two peptide IDs for x).
Note that for our experiments, since we only use results from three search
engines there can be only 1-1-1 (three way) or 1-1 (two way) ties in voting. When
breaking ties we can simply use the E-value or eFDR score of the single search
engine peptide ID in each voting bloc.
Initially, peptide IDs are gathered for all spectra from all search engines. Either
the search engine E-value or its eFDR score is used. Estimated FDR scores are
calculated for each search engine, per spectrum, based on search results for a decoy
(shuffled) database. The differences between voting heuristics are in how ties are
broken, and what scores are assigned to the selected peptide ID. The following
heuristics were tested:
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MIN-Evalue Combiner. Select peptide ID with the minimum (best) search engine
E-value, regardless of number of votes. Does not rely on voting or consensus.
MIN-eFDR Combiner. Select peptide ID with the minimum (best) estimated FDR,
regardless of number of votes. Does not rely on voting or consensus.
V-Evalue Combiner. Select peptide ID with the largest number of votes. Break ties
by selecting peptide ID with minimum (best) search engine E-value. Assign score
as minimum E-value among agreeing peptide IDs. Intuitively, the E-value combiner
relies on the accuracy of unnormalized scores output by each search engine. Search
engines reporting more optimistic scores will have a greater effect on the scores
output by the E-value combiner heuristic.
V-MIN eFDR Combiner. Select peptide ID with the largest number of votes.
Break ties by selecting peptide ID with minimum (best) eFDR. Assign score as
minimum eFDR among agreeing peptide IDs. Intuitively, selecting the minimum
eFDR represents an optimistic estimate of statistical significance of the selected
peptide ID.
V-MAX eFDR Combiner. Select peptide ID with the largest number of votes.
Break ties by selecting peptide ID with minimum (best) eFDR. Where there are
multiple agreeing peptide IDs, assign score as the maximum eFDR among the agree-
ing peptide IDs. Intuitively, selecting the maximum eFDR represents a conservative
estimate of statistical significance of the selected peptide ID. Note that V-MIN and
107
V-MAX will always assign the same peptide ID to a spectrum. The only difference
is in the score assigned to the peptide ID.
V-Random Combiner. Select peptide ID with the largest number of votes. Break
ties by randomly selecting peptide ID with equal probability. Assign score by ran-
domly selecting scores from agreeing peptide IDs (with equal probability). Intu-
itively, the random combiner represents a middle-of the road estimate of statistical
significance of the selected peptide ID.
Pre-determined Combiners. Select peptide ID with the largest number of votes.
Break ties based on a predetermined ordering between search engines. V-TMO
(Tandem > Mascot > OMSSA), V-MTO (Mascot > Tandem > OMSSA), and
V-OMT (OMSSA > Mascot > Tandem) represent three possible fixed orderings
between search engines. Assign score among agreeing peptide IDs using the same
ordering. Intuitively, the pre-determined combiner represents a preference for a
particular search engine.
Vote-3 Combiner. Similar to the V-MIN eFDR combiner, but only selects peptide
IDs if all three search engines agree on the peptide selected. Intuitively, the Vote-3
Combiner is the most conservative consensus-based combiner.
Vote-2 Combiner. Similar to the V-MIN eFDR combiner, but only selects peptide
IDs if all three search engines agree on the peptide selected, or if two search engines
select the same peptide and the third search engine does not select any peptide.
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Intuitively, the Vote-2 Combiner is a conservative consensus-based combiner which
allows a single search engine to veto any peptide ID if it chooses a different peptide
for a spectrum.
3.3.5 PepArML Framework
3.3.5.1 Supervised Machine Learning Algorithm
The machine learning combiner PepArML (Peptide identification Arbiter by
Machine Learning) models the peptide identification problem as a classification prob-
lem. PepArML classifies each spectrum’s peptide IDs, generated by one or more
search engines, as either true or false with some confidence. For each spectrum, the
peptide ID classified as true with highest confidence is the predicted correct peptide
ID.
Feature vector. In addition to raw scores and E-values, search engines compute
(and report) many additional metrics characterizing peptide IDs (e.g., number of
matched ions). Using a machine learning framework makes it possible to use these
additional metrics to predict the correctness of peptide IDs with little additional
effort. A feature vector is constructed for each peptide identification, per spectrum
(peptide-spectrum pair). Figure 3.11 shows the structure of vector. It consists
of scores, E-values and additional metrics from each search engine. When search
engines assign spectra to different peptides, the score, E-value, and other metrics
computed by a search engine may be absent for particular peptide-spectrum pair, in
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which case the values are set to sentinels. An additional sentinel feature, per search
engine, is set to indicate the presence or absence of the search engine’s features for
a particular peptide-spectrum pair. Scores and other metrics can be extracted or
computed directly from the search engines’ outputs, and easily added to the feature
vector. At current stage of PepArML design, there is no effort made to eliminate fea-
tures that may be correlated or have poor predictive performance. Current peptide
ID feature vector is shown in Table 3.5.
Figure 3.11: Feature Vector
Random Forest training (5-fold) and testing. For PepArML we chose to use the
Random Forest algorithm, developed by Leo Breiman, a statistician at the Univer-
sity of California Berkeley. It is a meta machine learning classifier which builds
multiple decision trees. Each tree is built with random training samples and ran-
domly selected attributes set at each tree node. The final decision is made by the
result of majority vote. We chose Random Forest because it doesn’t impose any
statistical models on the attribute distribution, and thus should yield better oppor-
110





3 Precursor mass delta
4 # of matched y-ions
5 # of matched b-ions
6 # of missed cleavage





11 Precursor mass delta
12 # of matched ions
13 # of matched peaks





18 # of matched ions
19 E-value
20 Sentinel
Table 3.5: Peptide ID feature vector, with features from Tandem, Mascot, and
OMSSA.
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tunities for actual data properties to decide the peptide identification results.
The classifiers were trained with all possible combinations of search engines.
Classifiers using only the features of Mascot, OMSSA, and Tandem, are denoted
C-M, C-O, and C-T, respectively. Classifiers C-MO, C-TM, and C-TO use features
from Mascot and OMSSA; Tandem and Mascot; and Tandem and OMSSA, respec-
tively. Classifier C-TMO uses features from all three search engines. Each classifier
is trained and tested using 5-fold cross validation. Since the number of false peptide
IDs is larger than the number of true peptide IDs, the false peptide IDs were down-
sampled before training so that each training data set has equal number of true and
false examples.
3.3.5.2 Unsupervised Learning
For tandem mass spectra data sets derived from synthetic protein mixes, train-
ing peptide IDs can be classified as true or false based on the identity of proteins
known to be in a sample. In practice, however, the protein content of biological
samples is not known in advance. Peptide ID training sets thus cannot be con-
structed based on ground truth. One of the major novel features of PepArML is an
unsupervised training procedure developed for this case.
The unsupervised training procedure relies on two key observations. First,
many proteins in a sample can typically be confidently identified by database search
engines, even if not all the peptides or spectra from these proteins can be confidently
identified. For instance, in experiments biologists frequently consider a protein to
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be positively identified if two or mass spectra are assigned with high confidence to
peptides from that protein.
Once a protein is positively identified (based on some quality criteria), PepArML
can then also label all other peptide IDs assigned to the protein as correct peptide
IDs in the training data. This property is where peptide identification differs from
generic machine learning classification problems. Since a single protein sequence is
longer than and can thus contain multiple short peptide sequences, assuming a pro-
tein to be correct based on two or more peptide IDs allows us to potentially assign
true labels to many other peptide IDs for the protein, despite their lower confidence.
The second observation on which the PepArML unsupervised training pro-
cedure is based is that for peptide identification, machine learning models can be
successfully trained even if the training labels are not completely correct. Classifica-
tion results from interim machine learning models may be used to re-label training
data and iteratively build more accurate models. PepArML takes advantage of this
observation to begin training models initially based on one or more high-confidence
putative true proteins, then iteratively improve the accuracy of each model by using
its classification results to label training data for newer models.
3.3.5.3 Unsupervised Learning Algorithm
The unsupervised peptide identification is carried out in an iterative procedure.
A set of putative true positive proteins are selected based on input search engines’
results, and are used to label peptide IDs. Machine learning is then applied and
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a peptide ID classifier is trained. The trained peptide ID classifier is then used
to select new putative true positive proteins. The procedure is then iterated until
convergence. The algorithmic steps are:
Select putative true positive proteins by consensus. First, consensus peptides that
all search engines agree on are selected as initial putative true peptides. Proteins that
contain at least two such peptides and have a significant fraction of their sequence
(e.g., 10%) covered by these peptides are selected as initial putative true positive
protein set.
Iteratively refine the putative true positive proteins. Given putative true positive
proteins, all peptide IDs associated with these proteins are labeled true, with all
other peptide IDs labeled false. A classifier is trained based on the labeled data
with 5-fold cross-validation. Peptide IDs predicted as true, below some estimated
FDR value (e.g., 0.2), are selected. Proteins that contain at least two such peptides
and have certain sequence (e.g., 10%) covered by predicted true peptides are selected
to form a new putative true positive protein set.
Termination. The iterative procedure continues until the content of putative true
positive protein set is stable.
We emphasize that the set of putative true positive proteins need not to be
completely correct in order for this iterative training procedure to be successful. In
fact, we will show later in Section 3.3.8.8 that the unsupervised PepArML iterative
training method can robustly handle omission of true positive proteins, even to the
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extent of starting training with only peptide IDs from a single true protein labeled
as true.
3.3.6 Implementation
PepArML is implemented using the software package Weka [WF05]. (Waikato
Environment for Knowledge Analysis). Weka was developed by a machine learning
research group at the University of Waikato at New Zealand for data mining. The
whole package is written in Java, and contains tools for data pre-processing, clas-
sification, regression analysis, clustering, association rules, and visualization. The
code was downloaded from http://www.cs.waikato.ac.nz/ml/weka/. We selected
Weka because of its popularity in the machine learning community.
Weka contains implementations of a number of machine learning classification
algorithms. We tested several, including Logistic Regression, support vector ma-
chines (SVM), Random Forest, AdaBoost, and naive Bayes. We chose to use the
Random Forest classifier for PepArML since it consistently outperformed the others.
3.3.7 Experimental Framework
3.3.7.1 Mass Spectra Data Sets
Three LC-MS/MS data sets were selected for evaluating the proposed ap-
proach. They were generated with known protein mixtures by three different in-
struments. The instruments use a variety of ionization, mass measurement, and
fragmentation technologies. The data sets are labeled as C8, S17, and AURUM.
115
C8 A mixture of 20ng each of eight protein standards (Table 3.6 lists the 8 pro-
teins in the sample plus Trypsin) was prepared. Urea and DTT were added
with final concentrations of 8 M and 1 mg/mL, respectively, and incubated at
37℃ for 2 hr under nitrogen. Iodoacetamide was added to a concentration of 2
mg/mL and kept at room temperature for 1 hr in the dark. Trypsin was added
at a 1:20 (w/w) enzyme to substrate ratio and incubated overnight at 37℃.
The protein digest was desalted using a reversed-phase trap column (Michrom
Bioresources, Auburn, CA) and lyophilized to dryness using a SpeedVac (Ther-
moSavant, San Jose, CA), and then stored at -80℃.
For LC-MS the peptide mixture was injected onto a trap column (3 cm x 200
micron i.d. x 365 micron o.d.) packed with 5 micron porous C18 reversed-
phase particles. The peptide fraction was subsequently analyzed by nano-
RPLC equipped with an Ultimate dual-quaternary pump (Dionex, Sunnyvale,
CA) connected to a fused-silica capillary (50 micron i.d. x 365 micron o.d.).
This 15-cm long capillary was packed with 3-micron Zorbax Stable Bond (Ag-
ilent, Palo Alto, CA) C18 particles.
Nano-RPLC separation was performed at a flow rate of 200 nL/min using a
5-45% linear acetonitrile gradient over 100 min with the remaining 20 min for
column regeneration and equilibration. The peptide eluants were monitored
using a linear ion-trap mass spectrometer (LTQ, ThermoFinnigan, San Jose,
CA) operated in a data dependent mode. Full scans were collected from 400–
1400 m/z and 5 data dependent MS/MS scans were collected with dynamic
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exclusion set to 30 sec.
C8 contains a total of 3812 MS/MS spectra, including 504 (13.2%) true positive
spectra assignable to peptides from the expected proteins.
S17 1244 MS/MS spectra from the Sashimi project data repository (http://sashimi.
sourceforge.net) data set 17mix test2, representing a tryptic digest of stan-
dard proteins (Table 3.7 lists proteins in the sample) analyzed with a Micro-
mass Q-TOF Ultima. The S17 data set contains 247 (19.9%) true positive
spectra assignable to peptides from the expected proteins.
AURUM 10082 MS/MS spectra from the Aurum 1.0 data set [FVK+07]. Spectra
were generated using a MALDI TOF-TOF instrument, (Applied Biosystems
4700) from 246 commercially sourced human proteins synthetically expressed
in E. coli, checked for purity, digested with trypsin, and spotted, one protein
per MALDI spot, for analysis. All spectra from spots with AURUM peptide
identification annotations were used. The AURUM data set contains 4061
(40.3%) true positive spectra assignable to peptides from the AURUM anno-
tation proteins.
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Name Accession Description Organism
1. ADH1 YEAST P00330 Alcohol dehydrogenase 1 S. cerevisiae
2. PYGM RABIT P00489 Glycogen phosphorylase O. cuniculus
3. CAH2 BOVIN P00921 Carbonic anhydrase II B. taurus
4. ALBU BOVIN P02769 Serum albumin B. taurus
5. SODC BOVIN P00442 Superoxide dismutase B. taurus
6. CYC HORSE P00004 Cytochrome c E. caballus
7. MYG HORSE P68082 Myoglobin E. caballus
8. RNAS1 BOVIN P61823 Ribonuclease pancreatic B. taurus
9. ADH2 YEAST P00331 Alcohol dehydrogenase 2 S. cerevisiae
10. TRYP PIG P00761 Trypsin S. scrofa
Table 3.6: Proteins in Calibrant protein mixture (C8).
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Name Accession Description Organism
1. AMY BACLI P06278 Alpha-amylase B. licheniformis
2. BGAL ECOLI P00722 Beta-galactosidase E. coli
3. PPB ECOLI P00634 Alkaline phosphatase E. coli
4. OVAL CHICK P01012 Ovalbumin G. gallus
5. G3P RABIT P46406 Glyceraldehyde-3-phosphate O. cuniculus
dehydrogenase
6. MLE1 RABIT P02602 Myosin O. cuniculus
7. PYGM RABIT P00489 Glycogen phosphorylase O. cuniculus
8. ALBU BOVIN P02769 Serum albumin B. taurus
9. MYSS RABIT P02562 Myosin heavy chain O. cuniculus
10. CAH2 BOVIN P00921 Carbonic anhydrase B. taurus
11. CASB BOVIN P02666 Beta-casein B. taurus
12. CATA BOVIN P00432 Catalase B. taurus
13. LACB BOVIN P02754 Beta-lactoglobulin B. taurus
14. LALBA BOVIN P00711 Alpha-lactalbumin B. taurus
15. TRFE BOVIN Q29443 Serotransferrin B. taurus
16. ACTA HUMAN P62736 Actin H. sapiens
17. ALBU HUMAN P02768 Serum albumin H. sapiens
18. MYG HORSE P68082 Myoglobin E. caballus
19. PHS2 RABIT Glycogen Phosphorylase O. cuniculus
20. MLRS RABIT P02608 Myosin regulatory light chain 2 O. cuniculus
21. MLRT RABIT P24732 Myosin regulatory light chain 2 O. cuniculus
22. MYH2 RABIT Myosin O. cuniculus
23. MYH1 RABIT Myosin O. cuniculus
24. MYH13 RABIT Myosin O. cuniculus
25. MYH4 RABIT Q28641 Myosin-4 O. cuniculus
26. MYH8 RABIT Myosin O. cuniculus
Table 3.7: Proteins in Sashimi protein mixture (S17).
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3.3.7.2 Tandem Mass Spectra Search Engines and Protein Sequence
Database
Three sequence database search engines were used to identify the tandem
mass spectra: X!Tandem [CB04], Release 2007.07.01; MASCOT [PPCC99], version
2.1.03; and OMSSA [GMK+04], version 2.1.0. Search parameters are summarized
in Table 3.8. For X!Tandem, refinement mode is turned off to make sure X!Tandem
doesn’t take advantage of the refined search procedure.
Two protein sequence databases were used: UniProtKB/Swiss-Prot (version
53.0) and Human International Protein Index (IPI-Human) (version 3.32). Data sets
C8 and S17 were searched against Swiss-Prot, while data set AURUM was searched
against IPI-Human. For each sequence database, a decoy database was also created.
It consists of randomly shuffled sequences. Search results from the decoy database
were used for estimating false discovery rates (FDR), using the method described
by Elias et al. [EHFG05a].
When searching tandem mass spectra data sets against protein sequence databases,
each search engine generates zero, one, or more peptide IDs for each spectrum. Also
because each search engine has its own algorithm for selecting candidate peptides,
filtering noisy spectra, assigning peptide ID score and assessing the quality and sta-
tistical significance of peptide-spectrum match, the peptide IDs are different among
search engines.
For the proposed approach, only the top ranked peptide ID is extracted from
each search engine for each spectrum. Peptide IDs corresponding to an expected
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protein, which belongs to the synthetic protein mix or the selected putative true
protein set, are considered correct. The vector corresponding to this peptide is
assigned as “true”, regardless of E-value, score or number of agreeing search engines.
All other peptide IDs are considered incorrect and the corresponding vectors are
assigned as “false”.
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Search Parameter C8 S17 AURUM
Data Base Swiss-Prot Swiss-Prot IPI Human
Mass Error Unit Dalton Dalton Dalton
Fragment Mass Tolerance 0.6 0.2 0.4
Parent Mass Tolerance 2.0 2.0 2.0
Maximum Missed Cleavages 1 1 1
Enzyme Trypsin Trypsin Trypsin
Fixed Modification Carbamidomethyl(C) Carbamidomethyl(C) Carbamidomethyl(C)
Variable Modification Oxidation(M) Oxidation(M) Oxidation(M)
Table 3.8: Search Engine Parameters for Spectra Data Sets
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3.3.8 Experimental Results
3.3.8.1 Search Engine E-value vs. Estimated False Discovery Rate
We first briefly examine the peptide identification scoring technique for each
search engine. In Figure 3.12, the left column compares each search engine’s esti-
mated statistical significance (E-values) and false discovery rate (FDR). The results
are collected based on three spectra data sets searched with three search engines.
Since E-value for certain score S is defined as the estimated number of false peptide
identifications with score equal or better than S, and FDR is defined as the per-
centage of false positives among the declared significant results, E-value and FDR
represent similar concepts when measuring the sensitivity of peptide identification
results.
Ideally, there should be linear correspondence between E-values calculated
by each search engine and experimentally measured FDR. However, we see in Fig-
ure 3.12 that the actual result are quite different. E-values for both Tandem and
Mascot tend to increase quickly for low FDR values, then level out and grow much
more slowly. OMMSA E-values are linear but fairly flat. In addition, we see that
E-values do not correspond to actual measured FDR. For instance, an E-value of 0.5
implies that half of all predictions are correct. However, the graph for each search
engine E-value=0.5 does not yield the appropriate FDR for each data set.
Comparing E-values produced by different search engines is also difficult. Be-
cause the statistical models for estimating E-values are different in each search
engine, the same E-value given by different search engines may correspond to differ-
123
ent FDR. In practice results show E-values of search engines were frequently overly
optimistic or pessimistic. E-values thus do not appear to be sufficiently precise to
estimate the number of false hits by each search engine. Even worse, not only is the
correlation between E-values and FDR poor, the relative accuracy for each search
engine changes for different data sets. We can conclude that E-values are unlikely
to be a good metric for comparing search engine performance or combining multiple
search engine results.
In comparison, we found that estimated FDR (eFDR) values were better cor-
related to true FDR values. The right column of Figure 3.12 presents the true
FDR values for corresponding eFDR values for all three data sets. The correla-
tion between eFDR and FDR is much better than between E-values and FDR. We
see that eFDR values computed from decoy databases are somewhat pessimistic
(under-predicting true FDR) but generally linearly correlated, and more consistent
than E-values across all three data sets. Estimating FDR based on experimental
decoy (reverse/shuffle) database search thus appears to be a better approach for
predicting the statistical significance of peptide IDs.
3.3.8.2 Heuristic Combiner Comparisons
Next, we compare the sensitivity of the different heuristics for combining search
engine results. Figures 3.13, 3.14 and 3.15 show the ROCs of different heuristics for













































































Figure 3.12: Correlation between FDR, E-value and estimated FDR
125
The main observation is that both the absolute and relative performance of
each heuristic combiner is data set dependent. For C8 V-MIN and MIN-eFDR tend
to be the most sensitive, and Vote-3 and V-MAX the least. For S17 Vote-3 and
Vote-2 are the most sensitive, while V-MAX is significantly worse than all other
combining heuristics (except for very small FPR values, where it is the best). For
AURUM V-MIN and MIN-eFDR are again the most sensitive. V-MAX and V-OMT
are the least sensitive, but only by a small margin.
Overall, we see that the V-MAX combiner tends to be less accurate than the
other heuristics. Apparently always conservatively selecting higher (worse) eFDR
values for its output appears to reduces the heuristic’s sensitivity. Vote-3 appears
to be too conservative for C8, but not for the other data sets.
The performance of the voting heuristic V-MIN and the non-voting heuristic
MIN-eFDR are very similar. Both heuristics choose the minimum (best) eFDR
value, but V-MIN only does so among the peptide IDs with the greatest agreement.
For our datasets the similarity in the output of the two heuristics indicate the best
eFDR values usually occurs only in the largest group of agreeing peptide IDs. In
other words, agreement and high eFDR scores are very well correlated in our data
sets.
Similar to V-MIN and Min-eFDR, the sensitivity of the voting heuristic V-
Evalue and the non-voting heuristic MIN-Evalue are also very similar. Both heuris-
tics choose the minimum (best) E-value, but V-Evalue only does so among the
peptide IDs with the greatest agreement.
The power of consensus is demonstrated by the sensitivity of the Vote-3 and
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Vote-2 heuristics for the S17 data set, where for FPR values between 0.02 and
0.1 either Vote-3 or Vote-2 is significantly more sensitive than the other heuristics.
However, Vote-3 and Vote-2 do not perform as well for the C8 and AURUM data
sets.
In most cases, results seem to indicate that except for V-MAX, the perfor-
mance of the eFDR based heuristic combiners (V-MIN, V-Random, V-TMO, V-
MTO, and V-OMT) are about the same, with V-MIN slightly more sensitive overall.
This seems to indicate that search engine eFDR scores are fairly similar when the
same peptide ID is selected.
Finally, comparing the use of E-values (V-Evalue and MIN-evalue) versus
eFDR scores (V-MIN, MIN-eFDR, etc.), we see that heuristics using E-values per-
form well for AURUM (tied with eFDR) but are slightly less sensitive for C8 and
S17.
Since the V-MIN combiner usually achieves the best sensitivity, we will refer
to it as Voting and use it as the representative voting heuristic for comparisons with
machine learning methods in the remainder of the chapter.
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Figure 3.13: Heuristics for C8 Spectra Set
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Figure 3.14: Heuristics for S17 Spectra Set
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Figure 3.15: Heuristics for AURUM Spectra Set
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C8 S17 AURUM
Classifiers 10% FPR 20% FPR 10% FPR 20% FPR 10% FPR 20% FPR
MIN-Evalue 0.74 0.77 0.69 0.81 0.85 0.88
MIN-eFDR 0.78 0.82 0.76 0.80 0.86 0.89
V-Evalue 0.73 0.75 0.70 0.79 0.84 0.87
V-MIN 0.78 0.81 0.75 0.79 0.85 0.88
V-MAX 0.65 0.73 0.57 0.65 0.79 0.83
V-Random 0.72 0.75 0.68 0.76 0.80 0.83
V-TMO 0.69 0.72 0.72 0.77 0.83 0.87
V-MTO 0.67 0.71 0.72 0.78 0.79 0.81
V-OMT 0.76 0.80 0.64 0.70 0.77 0.80
Vote-2 0.73 0.75 0.76 0.80 0.81 0.84
Vote-3 0.57 0.61 0.71 0.77 0.76 0.79
Table 3.9: Sensitivity vs. False Positive Rate (FPR) for Heuristic Combiners. Best
sensitivity for each FPR & data set in bold.
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3.3.8.3 Voting Heuristics vs. Search Engine Comparisons
We now compare the sensitivity of some voting heuristics (V-MIN, Vote-2,
Vote-3) with that of the individual search engines (Tandem, Mascot, OMSSA).
Figures 3.16, 3.17, and 3.18 show the resulting ROC curves.
We see that even relatively simple heuristic combiners can improve sensitivity.
except for very low FPR values (< 0.01), heuristic combiners are more sensitive
than any individual search engine. At higher FPR values, only the Vote-3 heuristic
combiner is less sensitive than individual search engines. This result is in line with
earlier observations that individual search engines miss many correct peptide IDs
found by other search engines. In fact, no single search engine is consistently more
sensitive than the others across all three data sets. OMSSA is most sensitive for C8,
Mascot for S17, and Tandem for AURUM.
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Figure 3.16: Heuristics vs. Single Search Engine Comparison for C8 Spectra Set
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Figure 3.17: Heuristics vs. Single Search Engine Comparison for S17 Spectra Set
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Figure 3.18: Heuristics vs. Single Search Engine Comparison for AURUM Spectra
Set
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3.3.8.4 Supervised Machine Learning Performance
Having seen that heuristic combiners work quite well, we now explore whether
machine learning is really needed to combine search engine results. We present our
experimental evaluation in three sets of graphs: ROC curves, sensitivity vs. FDR
plots, and sensitivity vs. estimated FDR (eFDR) plots. Results for each data set are
placed in six separate graphs to make comparisons easier (with data for the voting
heuristic and overall combined classifier C-TMO replicated on all graphs).
ROC Curves
We begin with classic ROC curves that compare sensitivity and selectivity
tradeoffs for each algorithm. Classifier and search engine ROC curves for each data
set are shown in Figures 3.19 (C8), 3.20 (S17), and 3.21 (AURUM), with six sets
of graphs for each data set. In each graph, the y-axis represents true positive rate
(sensitivity), and the x-axis represents false positive rate (1-specificity). The three
graphs on the left of each figure present ROC curves for classifiers C-T, C-M, and
C-O (displayed as solid lines) and for search engines Tandem, Mascot, and OMSSA
(displayed as dotted lines). The three graphs on the right of each figure present ROC
curves for classifiers C-TM, C-MO, and C-TO (displayed as solid lines). ROC curves
for C-TMO (displayed as dash-dotted lines) and Voting (V-MIN eFDR) (displayed
as dashed lines) are included in all graphs for comparison. Note that the ROC































































































Figure 3.19: ROC curves for C8. Classifiers (solid line) and search engines (dotted
line) are presented in each graph. C-TMO classifier (dash-dotted line) and Voting






























































































Figure 3.20: ROC curves for S17. Classifiers (solid line) and search engines (dotted
line) are presented in each graph. C-TMO classifier (dash-dotted line) and Voting






























































































Figure 3.21: ROC curves for AURUM. Classifiers (solid line) and search engines
(dotted line) are presented in each graph. C-TMO classifier (dash-dotted line) and
Voting combiner (dashed line) are included in all graphs.
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C8 S17 AURUM
Classifiers 5% FPR 10% FPR 5% FPR 10% FPR 5% FPR 10% FPR
C-TMO 0.79 0.86 0.76 0.85 0.87 0.91
C-TM 0.73 0.77 0.79 0.81 0.86 0.91
C-MO 0.74 0.82 0.73 0.80 0.80 0.83
C-TO 0.76 0.84 0.75 0.79 0.86 0.88
C-T 0.67 0.70 0.71 0.74 0.84 0.88
C-M 0.65 0.70 0.71 0.77 0.78 0.83
C-O 0.68 0.78 0.60 0.69 0.69 0.73
Voting 0.73 0.78 0.63 0.75 0.81 0.85
Table 3.10: Sensitivity vs. False Positive Rate (FPR) for Classifiers. Best sensitivity
for each FPR & data set in bold.
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Table 3.10 presents the sensitivity at 5% and 10% FPR for each classifier and
Voting heuristic combiner. These values correspond to the height of each curve at
the 0.05 and 0.1 points on the x-axis of each of the ROC graphs.
The main observation is that C-TMO (dash-dotted line), the classifier built
using all three search engines, generally yields the best sensitivity overall. Minor
exceptions exist for very small values of FPR, particularly when compared to C-T
for S17. C-TMO outperforms not just single search engine scores and classifiers,
but also the V-MIN heuristic combiner. Differences are small for very small FPR
values, but by 10% FPR the increase in sensitivity is significant. Combining results
using machine learning thus appears more successful than heuristic combiners.
As previous researchers have discovered, results also show classifiers using only
features from a single search engine (solid lines on left) are generally more sensitivity
than the original search engines (dotted lines on left). Gains are consistent for C-T
and C-M; however, C-O (the classifier built using features from OMSSA) is less
sensitive than OMSSA for AURUM and for low FPR values for C8, possibly due to
the small number of features output by OMSSA.
Finally, results demonstrate that classifiers built using features from two search
engines (C-TM, C-MO, C-TO, solid lines on right) are almost as sensitive as C-
TMO. Overall, sensitivity results vary somewhat depending on the data set tested,
but general trends remain mostly consistent.
Similar observations may be drawn from the area under ROC (AUROC) plots
in Figure 3.22. Note that our ROC graphs display the section of ROC of greater
interest to biologist (FPR values between 0 and 0.2), but AUROC is computed as
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Figure 3.22: AUROC for each classifier and search engine. The y-axis represents the
area under the ROC curve (AUROC) for each classifier. Each classifier is displayed
as a bar and arranged along the x-axis. Classifiers are arranged in three groups, one
for each data set.
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the area under the full ROC graph (FPR values between 0 and 1). Results show that
when compared using AUROC, C-TMO is more sensitive than all other algorithms
for all three data sets.
Sensitivity vs. FDR
Previous ROC graphs measured sensitivity with respect to the false positive
rate (FPR). We now examine sensitivity achieved with respect to different values for
the false discovery rate (FDR). Because of the differences between FPR and FDR,
these results focus on sensitivity for score thresholds corresponding to very small
FPR values (on the far left) of ROC graphs.
Figures 3.23, 3.24 and 3.25 show relationship of sensitivity vs. FDR, with six
sets of graphs for each data set. In each graph, the y-axis represents sensitivity, and
the x-axis represents FDR. The three graphs on the left of each figure present the
curves for classifiers C-T, C-M, and C-O (displayed as solid lines) and for search
engines Tandem, Mascot, and OMSSA (displayed as dotted lines). The three graphs
on the right of each figure present the curves for classifiers C-TM, C-MO, and C-TO
(displayed as solid lines). The curve for C-TMO (displayed as dash-dotted lines) is






























































































Figure 3.23: Sensitivity vs. FDR curves for C8. Classifiers (solid line) and search
engines (dotted line) are presented in each graph. C-TMO classifier (dash-dotted






























































































Figure 3.24: Sensitivity vs. FDR curves for S17. Classifiers (solid line) and search
engines (dotted line) are presented in each graph. C-TMO classifier (dash-dotted






























































































Figure 3.25: Sensitivity vs. FDR curves for AURUM. Classifiers (solid line) and
search engines (dotted line) are presented in each graph. C-TMO classifier (dash-
dotted line) is included in all graphs.
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We see that as with ROC curves, in all three data sets the dash-dotted line
(representing C-TMO) is generally above all other lines (demonstrating greater sen-
sitivity). For AURUM C-TMO is almost always best, but for C8 and S17, some
Tandem-based classifiers (C-T, C-TO) have better sensitivity at smaller FDR val-
ues. These results confirm our earlier conclusions that combining search engine
results using machine learning is very sensitive.
A problem that is noticeable in these graphs is that for the C8 and AURUM
data sets at very small FDR values, even individual search engines have better
sensitivity than any classifier. It turns out that the sensitivity problem with very
low FDR values is caused by the underlying Random Forest algorithm employed by
classifiers. Setting the threshold at a very low FDR value is equivalent to selecting a
very small number of high-confidence peptide IDs. Search engines have no problems
with doing so, since they can just pick peptide IDs with very low E-values (e.g.,
10−60). Peptide ID scores generated by Random Forest, in comparison, are between
0 and 1.0 based on the fraction of decisions tree voting for the peptide ID. The best
score is 1.0, indicating all trees voted for the correctness of the peptide ID.
Since the current PepArML implementation uses 100 trees, with a large num-
ber of spectra we will find several peptide IDs with the highest score (1.0). Without
using additional trees, PepArML cannot distinguish the “best” peptide ID from this
top group. As a result the proportion of true peptide IDs within this top-scoring
group establishes the baseline minimum FDR reported in our experiments, prevent-
ing the classifier from improving performance for small FDR values.
For instance, assume 20 peptide IDs all receive the highest score from Random
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Forest (1.0, indicating unanimous yes votes from all trees). However, only 19 of the
peptide IDs are correct, meaning that the lowest FDR possible is 0.05 (1 in 20). In
comparison, when using just the search engine score, it is possible to achieve a FDR
of 0.0 if the highest scoring peptide ID is correct.
Using larger numbers of trees or other methods to distinguish between these
top-scoring, high confidence peptide IDs can ameliorate this problem for Random
Forest classifiers.
Sensitivity vs. Estimated FDR
We now examine sensitivity achieved for score thresholds representing different
estimated FDR (eFDR) values. Figures 3.26, 3.27 and 3.28 show relationship of
sensitivity vs. estimated FDR (eFDR), with six sets of graphs for each data set.
In each graph, the y-axis represents sensitivity, and the x-axis represents estimated
false discovery rate. The three graphs on the left of each figure present the curves
for classifiers C-T, C-M, and C-O (displayed as solid lines) and for search engines
Tandem, Mascot, and OMSSA (displayed as dotted lines). The three graphs on
the right of each figure present the curves for classifiers C-TM, C-MO, and C-TO
(displayed as solid lines). The curve for C-TMO (displayed as dash-dotted lines) is






























































































Figure 3.26: Sensitivity vs. eFDR curves for C8. Classifiers (solid line) and search
engines (dotted line) are presented in each graph. C-TMO classifier (dash-dotted






























































































Figure 3.27: Sensitivity vs. eFDR curves for S17. Classifiers (solid line) and search
engines (dotted line) are presented in each graph. C-TMO classifier (dash-dotted






























































































Figure 3.28: Sensitivity vs. eFDR curves for AURUM. Classifiers (solid line) and
search engines (dotted line) are presented in each graph. C-TMO classifier (dash-
dotted line) is included in all graphs.
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Because we can calculate estimated FDR using decoy databases, these graphs
indicate what sensitivity can be achieved in practice with real biological samples
for different algorithms. We find that unlike ROC curves, the data set chosen has
a significant impact on the relative performance of different algorithms. For the
AURUM data set C-TMO consistently achieves the best performance. C-TMO
performs almost as well for the S17 data set, except for very small eFDR values.
However, for the C8 data set C-TMO underperforms both the C-T, C-TM, and C-M
classifiers and individual search engines for small values of eFDR.
Note that the actual sensitivity of the classifier remains unchanged. The prob-
lem is caused by the difficulty of using eFDR to selecting the appropriate score
threshold for the desired sensitivity. These results point out potential difficulties
with using eFDR when ground truth is not known.
3.3.8.5 Machine Learning Method Comparisons
We also used Weka to compare different machine learning methods (Random
Forest, Logistic Regression, AdaBoost and Naive Bayes) to measure their perfor-
mance on all three data sets when when combining all three search engine results.
Table 3.11 describes the machine learning methods and their default parameters.
The performance of these machine learning methods for combining all three
search engines are compared in Figures 3.29, 3.30 and 3.31. Each figure gives the
ROC curves of different machine learning methods. Results for SVM on data set
AURUM are omitted because of its long running time.
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Algorithms Description
Logistic Regression Build multinomial logistic regression model with a ridge
estimator. The log-likelihood of ridge value is 1.0E-8 and
maximum number of iterations is -1.
SVM The polynomial kernel:
K(x, y) =< x, y >p or K(x, y) = (< x, y > +1)p, p = 4
John Platt’s sequential minimal optimization algorithm
for training.
Random Forest Construct a forest of random trees with unlimited depth
of trees and the number of trees to be generated is 10.
AdaBoost Boost a nominal class classifier DecisionStump using the
Adaboost M1 method without resampling. Number of
iteration is 10 and weight threshold is 100.
Naive Bayes Naive Bayesian classifier using estimator classes.
Table 3.11: Machine Learning Classification Algorithms
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Figure 3.29: Machine Learning Classifiers for C8 Spectra Set
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Figure 3.30: Machine Learning Classifiers for S17 Spectra Set
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Figure 3.31: Machine Learning Classifiers for AURUM Spectra Set
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The performance of Random Forest appears to be best for all data sets, except
for smaller FPR values for C8. AdaBoost and Logistic Regression are almost as sen-
sitive, and naive Bayes and SVMs perform poorly. It is possible SVM performance
can be improved with a higher order polynomial kernel, but would be even more
computationally intensive.
3.3.8.6 InfoGain For Machine Learning Features
We assess the discriminating ability of each element of the feature vector us-
ing the information gain metric. The information gain of a feature measures the
reduction in entropy or randomness when the data set is subdivided according to
the feature’s values. Information gain, called InfoGain by Weka, is one of many
useful techniques for assessing the relative importance of each feature in machine
learning classifiers, and is a property of the data set, independent of the particular
classification algorithm used. Larger InfoGain values indicate a feature is likely to
be more useful in making accurate predictions.
The InfoGain values of search engine sentinels are of particular interest. Search
engine sentinels have value 0 or 1 depending on whether the search engine result con-
tains a particular peptide-spectrum assignment as a top-ranked peptide ID. Search
engine features, which take sentinel values when missing, also provide this infor-
mation, but the significance of the sentinel values is masked by the real feature
values. The InfoGain values for sentinels can therefore help gage the benefit of the
additional search engine features; features need to achieve larger InfoGain than the
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sentinels to demonstrate benefit over voting or consensus peptides.
Table 3.12 and Figure 3.32 shows InfoGain values computed by Weka for each
feature of the feature vector. We see that sentinels provide low InfoGain scores, indi-
cating that whether a search engine managed to make any prediction for a spectrum
to be not particularly useful. Similarly, the low InfoGain score for peptide length
indicates it is not a useful predictor of correctness. E-values and raw search engine
scores have among the highest InfoGain scores and thus provide important infor-
mation. Number of ions matched is also useful. Surprisingly, precursor mass delta
(the difference between expected vs. measured precursor mass) is a good indicator.
3.3.8.7 Generality of Machine Learning Model
Table 3.12 shows large variation in InfoGain and relative rank for each feature
between data sets. This suggests that a classifier model trained on one data set may
perform poorly when applied to another. To demonstrate this effect, we applied the
classifier trained on the C8 data set to the S17 data set, and compared its sensitivity
to a classifier actually trained on the S17 data set. The performance comparison
between two models are shown by ROC curves in Figure 3.33.
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Search Engine Feature C8 S17 AURUM
—
Peptide length 0.12 (14) 0.06 (20) 0.00 (20)
Tandem
Hyperscore 0.14 (9) 0.33 (6) 0.55 (2)
Precursor mass delta 0.13 (12) 0.31 (9) 0.47 (6)
# of matched y-ions 0.10 (16) 0.30 (10) 0.47 (7)
# of matched b-ions 0.07 (18) 0.19 (14) 0.36 (12)
# of missed cleavages 0.14 (11) 0.23 (13) 0.31 (13)
Sum of matched intensity 0.15 (8) 0.17 (16) 0.29 (14)
E-value 0.28 (5) 0.38 (3) 0.58 (1)
Sentinel 0.07 (19) 0.16 (17) 0.23 (16)
Mascot
Score 0.30 (3) 0.40 (2) 0.51 (4)
Precursor mass delta 0.12 (15) 0.33 (5) 0.43 (9)
# of matched ions 0.17 (6) 0.37 (4) 0.42 (11)
# of matched peaks 0.13 (13) 0.24 (12) 0.22 (17)
# of missed cleavages 0.14 (10) 0.18 (15) 0.26 (15)
E-value 0.28 (4) 0.40 (1) 0.52 (3)
Sentinel 0.06 (20) 0.10 (18) 0.19 (18)
OMSSA
p-value 0.34 (2) 0.32 (7) 0.47 (8)
# of matched ions 0.17 (7) 0.27 (11) 0.42 (10)
E-value 0.34 (1) 0.32 (8) 0.47 (5)
Sentinel 0.10 (17) 0.10 (19) 0.13 (19)















































































































































































Figure 3.32: InfoGain For Features
160





















Figure 3.33: ROC curves for C-TMO trained with S17 or C8, both applied to S17.
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The C8 classifier appears to be not very accurate when used to classify spectra
in the S17 data set, performing worse than the S17 classifier. This difference may
have many causes, ranging from differences in protein content, sample preparation,
mass spectrometers, search engine parameters, number of mass spectra, percentage
of true positive spectra, etc.
In general, when applying a classifier to a completely different data set, not
only could the machine learning algorithms choose sub-optimal features, but the
weights and thresholds estimated by training would be invalid if the characteristics
of the feature values changed too much. For example, E-values change with sequence
database size and precursor mass tolerance, and search engine scores tend to depend
heavily on the instrument fragment mass tolerance. We thus believe it is difficult
to generalize machine learning models trained on one data set for new data sets.
3.3.8.8 Unsupervised Machine Learning Performance
Since it appears difficult to construct generalized classifiers for use on a range
of data sets, for machine learning tools to be useful in practice, models must be
able to be automatically trained on the specific characteristics of each data set in an
unsupervised fashion. The unsupervised PepArML training procedure is designed
to be able to automatically predict correct labels for peptide IDs, making it possible
to train the classifier without supervision.
Section 3.3.5.3 describes the PepArML unsupervised training approach in de-
tail. Table 3.13 lists the actual parameters used by the current PepArML implemen-
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Initial Parameter Iterative Run Parameter
Non-overlap Protein eFDR Non-overlap Protein
peptides Coverage peptides Coverage
C8 ≥ 2 ≥ 0.3 ≤ 0.2 ≥ 2 ≥ 0.1
S17 ≥ 2 ≥ 0.1 ≤ 0.2 ≥ 2 ≥ 0.1
AURUM ≥ 2 ≥ 0.1 ≤ 0.5 ≥ 2 ≥ 0.1
Table 3.13: Parameters for Unsupervised Learning
tation of unsupervised training for each data set. Initially, only peptide IDs agreed
on by all three search engines are used to calculate the number of non-overlapping
peptides and protein coverage percentage. After the first classifier is trained, only
peptides with eFDR values below 0.2 (for C8 and S17) or 0.5 (for AURUM) are used
to calculate the number of non-overlapping peptides and protein coverage percent-
age.
To demonstrate the effectiveness of the unsupervised PepArML training proce-
dure, we compare its sensitivity to the supervised version of PepArML. The left side
of Figure 3.34 shows the ROC curves of supervised (dotted line) and unsupervised
(solid line) learning C-TMO classifiers applied to each data set.
These results clearly demonstrate the sensitivity of the unsupervised PepArML
classifier, since little is lost by using the heuristic unsupervised training procedure,
which is carried out without knowledge of the true proteins and peptide IDs.
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Figure 3.34: Left: supervised C-TMO (dotted), unsupervised C-TMO (solid), and
Voting (dashed). Right: unsupervised C-TMO starting with consensus proteins
(solid), or starting with single random true protein (dotted).
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C8 S17 AURUM
Classifiers 10% FDR 20% FDR 10% FDR 20% FDR 10% FDR 20% FDR
Unsup 0.00 0.89 0.70 0.83 0.83 0.83
C-TMO 0.00 0.63 0.67 0.75 0.77 0.79
C-TM 0.50 0.68 0.65 0.78 0.76 0.79
C-TO 0.00 0.55 0.66 0.72 0.75 0.77
C-MO 0.00 0.00 0.63 0.72 0.70 0.73
C-T 0.00 0.62 0.67 0.71 0.74 0.77
C-M 0.00 0.50 0.51 0.69 0.69 0.73
C-O 0.00 0.00 0.00 0.56 0.60 0.64
Tandem 0.46 0.55 0.46 0.62 0.73 0.77
Mascot 0.26 0.52 0.46 0.53 0.69 0.72
OMSSA 0.26 0.35 0.20 0.26 0.37 0.39
Table 3.14: Sensitivity vs. true FDR for supervised & unsupervised classifiers. Best
sensitivity for each FDR & data set in bold.
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C8 S17 AURUM
Classifiers 10% eFDR 20% eFDR 10% eFDR 20% eFDR 10% eFDR 20% eFDR
Unsup 0.69 0.84 0.60 0.69 0.82 0.83
C-TMO 0.00 0.50 0.67 0.72 0.76 0.78
C-TM 0.59 0.64 0.65 0.72 0.73 0.75
C-TO 0.00 0.00 0.61 0.69 0.85 0.94
C-MO 0.00 0.00 0.56 0.60 0.69 0.71
C-T 0.47 0.59 0.54 0.64 0.72 0.75
C-M 0.00 0.50 0.47 0.62 0.66 0.71
C-O 0.00 0.00 0.00 0.54 0.56 0.61
Tandem 0.52 0.56 0.42 0.49 0.72 0.74
Mascot 0.50 0.52 0.43 0.46 0.68 0.70
OMSSA 0.29 0.32 0.18 0.23 0.37 0.37
Table 3.15: Sensitivity vs. estimated FDR for supervised & unsupervised classifiers.
Best sensitivity for each eFDR & data set in bold.
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Tables 3.14 and 3.15 present the sensitivity of the unsupervised learning
PepArML classifier compared to other algorithms for at different FDR and eFDR
values.
While the performance evaluation results demonstrate that the unsupervised
learning PepArML procedure achieves similar sensitivity as the supervised learning
approach on all three data sets, its rate of convergence and tolerance for a poor
initial putative true protein set still needs to be established. If too many iterations
are required, or if small errors in initial protein set can result in large number of
nonsense predictions, then whether the technique can be applied to real experimental
data sets may be in doubt.
The graphs in the right column of Figure 3.34 show the convergence rate of
the unsupervised PepArML training procedure. The x-axis represents the training
iteration of the unsupervised classifier. The y-axis represents the AUROC of the
classifier after each iteration of training, evaluated with respect to the current pu-
tative true protein set. The solid line shows the convergence rate for the C-TMO
classifier using an initial putative true protein set selected based on the PepArML
algorithm (i.e., peptide IDs agreed on by all three search engines). The AUROC of
the classifier converges quickly, stabilizing within three iterations of training.
The robustness of the unsupervised learning PepArML is also tested by choos-
ing more challenging initial true positive protein sets representative of various types
of potential errors. The dotted lines in the graphs in the right column of Figure 3.34
show the rate of convergence when the initial putative true protein set consists of
just one randomly selected true positive protein for C8 and S17 data set (and ten
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randomly selected true positive proteins for AURUM data set). These cases repre-
sent starting from very conservative assumptions, where many true positive proteins
are falsely labeled as incorrect.
Despite many incorrectly labeled peptide IDs, with the PepArML unsupervised
training algorithm convergence of AUROC is quick and shows little evidence of
instability. This is particularly impressive for the AURUM data set which contains
hundreds of true positive proteins and for which the unsupervised learning PepArML
stabilizes after only three iterations. For data sets with a small number of true
positive proteins (C8), convergence is almost as quick as when using the full set
of putative true proteins. Similar quick convergence is also achieved with other
difficult initial putative true protein sets. As a result, we believe that unsupervised
PepArML is quite robust with respect to the choice of initial putative true protein
set, at least for synthetic protein mixes.
3.3.8.9 Discussion of Experimental Results
To recap, our experimental evaluation of the sensitivity and selectivity of in-
dividual search engines, combining heuristics, and machine learning classifiers pro-
vided considerable insight on their relative performance. Our major observations
were:
Comparing peptide identifications using estimated FDR (eFDR) is more effective
than comparisons using E-values. Results show eFDR is more closely correlated
to true FDR than search engine E-values, and heuristic combiners based on eFDR
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are more sensitive than combiners based on E-values.
Heuristic combiners can improve on single search engine scores. Improvement in
sensitivity based on The best-performing heuristic combiners demonstrate clear im-
provements in sensitivity over individual search engines for all three data sets tested.
If a machine learning framework such as PepArML cannot be readily applied, im-
plementing an eFDR-based voting heuristic combiner is still worthwhile.
Machine learning classifiers outperform single search engine scores. By exploiting
information in additional features, classifiers can significantly improve sensitivity be-
yond search engine scores, particularly when search engines provide many additional
useful features.
Classifiers based on multiple search engines outperform voting heuristic combiners.
The ability of machine learning classifiers to achieve greater sensitivity when com-
bining search engine results is likely due to a combination of more accurate modeling
of individual search engines, and ability to use non-score features.
Classifiers based on multiple search engines outperform classifiers based on features
from a single search engine. Classifiers generally benefit from additional informa-
tion. The best overall performance is generally achieved by C-TMO, the classifier
trained using data from all three search engines. It is unclear whether the perfor-
mance boost is due to complementary properties of features from different search
engines, or the incorporation of agreeing peptide ID information in the feature vec-
169
tor.
Adding features does not guarantee improved classifier performance. While addi-
tional features generally improve classifier performance, some features may provide
poor discrimination and interfere with machine learning, degrading performance. In
other cases, additional features may be highly correlated with existing features and
the benefit of additional peptide ID agreement is minimal.
Combining two search engines may be sufficient. Even though C-TMO usually
yields the most accurate results, classifiers constructed using only data from two
search engines (C-TM. C-MO, C-TO) often achieve similar sensitivity. This result
is particularly interesting from a commercial perspective, as C-TO, a classifier built
using only open source software, can approach the sensitivity of classifiers (C-TMO,
C-TM) that utilize features from Mascot, a commercial search engine. This suggests
that the machine learning combination of open-source search engines may be a viable
alternative to commercial search engines.
Unsupervised learning works well. Overall, we observe that the sensitivity of un-
supervised classifiers is very similar to that of supervised classifiers, sometimes even
better. Unsupervised PepArML performs well even for the AURUM data set, which
contains hundreds of proteins.
Applicability for biological samples. Our current success has been achieved with
data sets derived from synthetic protein mixes. Real biological samples are likely
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to be more complicated, and may require more robust algorithms, particularly for
unsupervised learning. Nonetheless, we believe PepArML demonstrates the poten-
tial for using machine learning to automatically combine search engine results and
features.
3.3.9 Conclusion
A highly sensitive and specific new technique is demonstrated here for sepa-
rating true from false peptide identifications on three synthetic protein mixture data
sets from both electrospray and MALDI instruments. PepArML uses machine learn-
ing to combine the search results from many search engines, achieving better results
than machine-learning or result combining alone. PepArML uses the model-free
random forest machine learning technique, which ensures that the relative contri-
butions of search engine agreement and peptide-spectrum match scores can be used
optimally for each combination of spectra, search engines, and search engine pa-
rameters. It is shown that PepArML can be trained effectively in an unsupervised
manner, making it possible to removes the need for extensive libraries of pre-trained
models based on experimental spectra from synthetic protein mixtures from all
instrument, search engine, and parameter combinations. Unsupervised PepArML
training also alleviates concerns about sub-optimal machine learning models being
applied beyond their ability to generalize effectively.
PepArML does not rely on specialized features or difficult to compute scores,
but these can be easily added to the model if desired. Similarly, PepArML can be
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used with any number of different search engines, or even multiple searches from
the same search engine. The model-free nature of PepArML combining even makes
it possible to combine results from disparate peptide identification techniques, such
as spectral matching, alongside search engine results, or to use paired searches with
conservative and aggressive search parameters.
The unsupervised training procedure could be manipulated in a variety of
ways to exercise more control over PepArML learning. Users could hand select the
initial set of putative true proteins, or apply a species constraint to the putative
true protein set, if the sample is known to come from a particular organism. It
would also be straightforward to incorporate peptide IDs to decoy peptides as known
false identifications just as other semi-supervised learning approaches have done.
However, the addition of known false peptide IDs is less powerful in this context
than correctly guessing true labels on a smaller number of spectra.
The excellent performance of PepArML applied to the results of Tandem and
OMSSA, both open-source, freely available search engines, raises the tantalizing
possibility that a PepArML based meta-search-engine might offer superior identi-
fication performance than costly commercial search engines. Such a meta-search-
engine could wrap Tandem, OMSSA, and other free search engines behind a single
user interface.
It remains to be seen whether the iterated unsupervised learning procedure
proposed here can be applied, as described, across the rich variety of experimen-
tal data sets. Our experiments to investigate the robustness of the procedure are
encouraging, but it is possible our simple technique for selecting putative true pro-
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teins, in particular, may find too few true positive proteins for successful training.
In future work, the plan is to investigate whether protein identification tools, such
as Protein Prophet [NKKA03], or an expectation-maximization (E-M) approach,
which would fit naturally into the iterative PepArML framework, might provide
additional robustness for PepArML when applied to experimental data sets.
The algorithm design and experimental results show that the proposed PepArML
machine-learning framework has the potential to solve the critical problems of com-
bining multiple search engine results and the use of machine-learning tools beyond




Conclusion and Future Work
4.1 Two Classes of Algorithms Demonstrate Good Performance and
Precision
In this thesis, three algorithms in the areas of genomics and proteomics were
designed, implemented and evaluated to demonstrate that applying high perfor-
mance computing techniques and statistical machine learning techniques can im-
prove both the performance and precision of bioinformatics algorithms. In addition
to developing several novel techniques, this thesis has performed extensive experi-
mental evaluation significantly beyond the scope of previously published research.
4.1.1 Genomics
In area of genomics, ESTmapper, a DNA to genome alignment algorithm was
designed and implemented to efficiently align cDNA sequences to genome(s) with
high speed and precision. It also provides flexibility of aligning cDNA sequences
to multiple chromosomes with high speed and accuracy. Experiment evaluation
results show that ESTmapper has comparable global alignment precision, and at
least 2–3 times faster compared to previous algorithms. With a more accurate
splice site model, ESTmapper can be used to find alternative splicing isoforms,
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cluster EST/cDNA sequences and help with gene finding.
The main contributions of ESTmapper are demonstrating the feasibility of
using suffix trees for entire genomes, techniques for estimating the statistical signif-
icance of DNA to genome alignments.
4.1.2 Proteomics
In the area of proteomics, two different algorithms for mass spectra based pep-
tide identification are designed and implemented to improve peptide identification
accuracy.
4.1.2.1 HMMatch
HMMatch was designed to use hidden Markov model to capture the mass
spectra peak intensity consensus and variation pattern. Each model summarizes
many examples of a peptide’s fragmentation spectrum in a generative probabilistic
model. The unassigned mass spectrum can be compared with HMMs to find its
peptide identification. Our preliminary experiment results show that HMMatch
has good specificity and superior sensitivity, compared to sequence database search
engines such as X!Tandem. As the size of publicly available mass spectra databases
continues to grow, it is possible to build a library of HMMs for peptide fragmentation
pattern. A relatively complete HMM mass spectra library can be a very good
complement to current database search based peptide identification methods.
The main contributions of HMMmatch are techniques for calculating statistical
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significance of HMM scores, and model extrapolation to peptides without experi-
mental mass spectra.
4.1.2.2 PepArML
PepArML is a machine learning based, model-free framework for peptide iden-
tification. It uses the Random Forest method to combine peptide identification
results from multiple peptide identification tools. Multiple matrices that compare
the similarity between theoretical and experimental spectra are combined under the
framework to distinguish true and false peptide identifications. An unsupervised
training approach makes it possible for PepArML to learn the properties of each data
set on the fly, removing the need to build a comprehensive library of pre-built models
based on instrument, search engine, and search parameter combinations. Our pre-
liminary results based on three search engines (X!Tandem, MASCOT, OMSSA) and
three synthetic protein mixture data sets from both electrospray and MALDI instru-
ments show the machine learning based framework outperforms machine learning
techniques applied to a single search engine’s output.
The main contributions of PepArML are demonstrating the effectiveness of
machine learning for combining features and scores from multiple search engines,
and techniques for unsupervised training for unlabeled mass spectra.
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4.1.3 Benefits of High Performance Computing and Machine Learn-
ing
Both high performance computing and machine learning techniques have been
widely applied to solving problems in bioinformatics field.
Currently, many bioinformatics problems (such as microarray gene expression
data analysis, genetic network, protein-protein interactions, phylogeny reconstruc-
tion, protein structure predictions, etc.) require computationally intensive operation
on a large data domain. It is impractical to solve these problems with only tradi-
tional sequential algorithms. Here both parallel computing techniques and carefully
designed data structure and algorithms are needed to save data processing time. So
high performance computing plays a very important role in solving these problems.
In this thesis, a novel sequence alignment algorithm is presented to demonstrate
the power of high performance computing techniques by aligning millions of cDNA
sequences to genomes within hours. The algorithm not only uses multiple processors
on both shared memory and distributed memory architecture, but also utilize suffix
tree data structure’s linear search speed for string match to speed up each cDNA
to genome alignment procedure. The results shows at least 2 - 3 times speed up
compared with other current popular sequence alignment softwares.
Machine learning techniques play key role in all bioinformatics research areas,
especially in genomics and proteomics areas. In this thesis, two machine learning
frameworks are designed and implemented to demonstrate machine learning’s appli-
cation in tandem mass spectra based peptide identification. HMMatch uses hidden
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Markov model’s probabilistic strength to capture the mass spectra peak intensity
consensus and variation pattern for spectral matching based peptide recognition.
It show superior sensitivity and specificity compared with current peptide identi-
fication methods. PepArML fully utilize the properties of mass spectra data and
random forest algorithm to design a unsupervised machine learning framework for
combining peptide identification results from multiple search engines. The machine
learning framework provides a more accurate method for classifying true from false
peptide identifications and improve peptide identification results.
4.2 Future Work
4.2.1 ESTmapper
ESTmapper is an efficient algorithm to align cDNA sequences to genome with
high accuracy and speed. It can help with identifying genome structure and provide
more accurate splice site information for training gene finding algorithms. Splice
site discovery is one of the most important issues in computational gene finding.
Some well-designed models have been built to predict splice sites. However, with
only a limited amount of accurate exon/intron boundary data available, most current
program use consensus sequences to predict splice sites. ESTmapper can be adapted
to include more accurate splice site model and branch site model to improve the
alignment accuracy. The improved ESTmapper can be used to identify a large
number of exon/intron boundaries, which can be used as training data for creating
more accurate splice site model and gene finders. It can also be used to detect
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alternative splicing isoforms and micro-exon, which is a challenging problem in the
field of bioinformatics.
4.2.2 HMMatch
HMMatch uses hidden Markov model to catch peptide fragmentation patterns
(mass spectra peak intensity and variation). It provides a more accurate solution
to the problem of recognizing seen peptide fragmentation patterns and thus a very
good complement algorithm for current database search based peptide identification
methods. As more and more mass spectra available to public, the next step work is
to build relatively comprehensive HMM libraries for certain species (Human, yeast,
etc.). Since it is fast to build single HMMs and using model extrapolation can
help avoid building HMM from scratch for some peptides (with single nucleotide
difference or post translational modification), mass spectra HMM libraries can be
built in reasonable amount of time. Such libraries can be used as the first step
of peptide identification by recognizing observed peptide mass spectra and thus
improve peptide identification accuracy. Database search based methods can then
be used to further identify the previously unobserved mass spectra patterns.
4.2.3 PepArML
PepArML uses random forest method to build model free framework to com-
bine peptide identification results from multiple peptide identification softwares
and provides better solution to separate true from false identifications. Current
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PepArML implementation is based on three search engines: X!tandem, MASCOT
and OMSSA and 20 metrics extracted from three search engines’ output results.
There is no feature design or selection involved in the whole process. So for the next
step of the work,
• More novel features (retention time, etc.) can be designed and included in the
PepArML framework. Poorly performing features can be removed.
• Different types of search engines (Sequest, Myrimatch, NIST MS-Search, HM-
Match, etc.) can be included to provide a more comprehensive view of the
peptide identification results.
• More stringent procedures may be designed to select true proteins for the
unsupervised iterative procedure.
• Can refine statistical model to assess the significance of peptide identification
results from PepArML.
After these refinements, PepArML can be used as a comprehensive framework
to combine current peptide identification softwares.
Bioinformatics is a relatively new research area. Both high performance com-
puting and machine learning techniques are widely used to solve challenge research
problems in this field. This thesis presented two typical problems and three carefully
designed solutions to demonstrate the power of both techniques for improving both
speed and precision of bioinformatics applications and algorithms. These techniques
can help biologists benefit from computer science research.
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